Carveol and Related Monoterpenes Inhibit the Function of the Human α7 Nicotinic Acetylcholine Receptor. by Lozon, Yosra Adnan
United Arab Emirates University
Scholarworks@UAEU
Theses Electronic Theses and Dissertations
3-2015
Carveol and Related Monoterpenes Inhibit the
Function of the Human α7 Nicotinic Acetylcholine
Receptor.
Yosra Adnan Lozon
Follow this and additional works at: https://scholarworks.uaeu.ac.ae/all_theses
Part of the Medical Sciences Commons
This Thesis is brought to you for free and open access by the Electronic Theses and Dissertations at Scholarworks@UAEU. It has been accepted for
inclusion in Theses by an authorized administrator of Scholarworks@UAEU. For more information, please contact fadl.musa@uaeu.ac.ae.
Recommended Citation
Lozon, Yosra Adnan, "Carveol and Related Monoterpenes Inhibit the Function of the Human α7 Nicotinic Acetylcholine Receptor."
(2015). Theses. 216.
https://scholarworks.uaeu.ac.ae/all_theses/216
lmEU a D..ia.J I ii.J.J I '" If u I La!J I Ci..st.a b ... r--' J L • United Arab Emirates University 
United Arab Emirates University 
College of Medicine and Health Sciences 
Department of Pharmacology 
CARVEOL AND RELATED MONOTERPENES INHIBIT THE 
FUNCTION OF THE HUMAN a7 NICOTINIC ACETYLCHOLINE 
RECEPTOR 
Y osra Adnan Lozon 
This thesi is submitted in partial ful fi lment of the requirements for the degree of 
Master of Medical Sciences ( Pharmacology and Toxicology) 
Under the Supervision of Professor Murat Oz 
March 2015 
II 
Declaration of Original Work 
1. Yo ra dnan Lozon, the undersigned, a graduate student at the Uni ted Arab 
mirale University (U EU), and the author of this thes is  entit led "Carveo! and 
related monoterpene inhihit the function of the human a nicotinic acetylcholine 
receptors", hereby, solemnly declare that this thesis is an original research work that 
has been done and prepared by me under the supervision of Professor Murat Oz, in 
the Col lege [Medicine and I Iealth c iences at UAEU. This work has not been 
previou I)' f0I111ed a the ba is for the award of an academic  degree, diploma or a 
im i lar t i t le at th i s  or any other univers i ty .  The materia ls borrowed from other 
source and inc luded in my thesis have been properly c i ted and acknowledged. 
Date __ ---'9c...!./---=b'--f'--{_� 
Copyright © 2015 Y osra A. Lozon 
Al l  Rights Reserved 
III 
Approval of the Master Thesis 
Thi Master The i i appro ed by the fol lowing Examirung ommittee Members: 
1 )  Ad i or ( ommittee Chai r): Prof. Murat Oz 
Title:  Pr fe or 
Department of Pharmaco log and Therapeutics 
o l lege of Medicine and Health Science , UAE Unjversity 
ignature JLu 1\;11./ 4 Date Y:> 1<, /2e, 15 
2 Member: Prof. Chris Howarth 
Tit le :  Profes or 
Department of PhysioLogy 
Col lege of Medic ine and Health Sciences, UAE Unjversity 
ignatur 
3 )  Member (External Examiner) : Prof. Nei l S. Mi l l ar 
Date 'J c J 3/1 S ( I 
iv 
Tit le :  Professor of Molecular Pharmacology, V ice-Dean (Enterprise), UCL 
Facul ty of  Life Sciences 
Department of Neuroscience, Physiology and Pharmacology 
I nstitution: Uillversity Col lege London 
Signature Q� �l.� 
This  1a ter The i is accepted by : 
Dean r the C !lege of Medic ine and Health c iences : Professor Dennis  Templeton 
Signalure�'::-- Date z.r-- s-- (� 
Dean of the Col lege of the Graduate Stud ie : Professor agi T. Wakim 
ignalur':...--, ,� 
. -
Copy $ ofJn. 
\ I 
Ab tract 
Plant and ph)'t chemicals have been u ed for centuries for therapeutic purposes. 
E sential o i l  fr m these plants are complex mixtures and may possess a large 
pectrum of biological act ivit ie many of them of c l inical intere l. mong the act ive 
constitu nt of es ential o i l s, monot rpenes, demonstrated valuable ant ioxidant, 
ant iv iraL ant imicrobial ,  antican er. analgesic and ant i - inflammatory effects. In recent 
years, acti n of monoterpene on the function of ion channels ha e been 
i nvest igated. In the present study, effects of d ifferent monoterpenes including 
carvacroL can'eo l,  d-carvone, eugenoL (+)-pulegone, thymol ,  thymoquinone, 
menthome and l i monene, on the function of the cloned a7 subunit of human 
nicot in ic acet) 1chol ine (oACh) receptor expressed in Xenopus oocytes were 
inve t igated by u ing the t\ o-electrode ol tage-clamp technique. Al l  monoterpenes 
caused a variable extent of reversible inh ibit ion of ACh (1 00 �lM)-induced currents 
except van i l l in and d-carvone. Carveol showed maximum potency of i nh ibi t ion with 
an ICso value of 8 . "  �M. The effect of carveol was further i nvestigated and found to 
be independent of the membrane potent ia l .  Carveol (1 0 �M) did not affect the 
act i  i ty of endogenous Ca2+-dependent cr chmmels since the extent of i nh ibi t ion by 
carveol was unaltered by the i ntrace l lu larly injected Ca2+ chelator BAPTA and 
perfusion with Ca2+-free bathi ng solution contain ing 2 mM Ba2+. The effect of 
carveol wa assoc iated with decreased potency of the ACh, and the i nh ibit ion was 
ful ly  reversed by increasing ACh concentrat ions, suggesting that th is drug acts i n  a 
competi t ive manner. I n  concl usion, these results demonstrate for the fi rst t ime that 
monoterpenes inhibi t  d i rectly the function of human a7 -nACh receptors expressed i n  
Xenopu oocytes. I t  appears that the extent of i nhibit ion b y  monoterpenes d iffers 
signi ficant ly depending on their chemical stmctures. 
Keywo rds: Monoterpenes, human nicot in ic a7 acetylchol ine receptors, carveol ,  
Xenopus oocytes. 
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Chapter 1: Introduction 
1. 1 .  I n t roduction to  Monoterpene 
Plant and phytoch micals have been used for centuries for therapeutic 
purpo e and c nsti tute the backbone of pharmacology and medicine .  I n  recent 
y ear , there ha been an increa ed interest in unvei l ing the biological activities of 
speci fic ph) tochemicals and understanding the mechanisms of action of their  
molecular and cel l ular effects. One of the major, biological ly active groups of 
phytochemicals are the terpenes. Terpenes are a large and diverse group of natural l y  
occurring compound that exist as the main const i tuents of essential o i l s  of several 
plant fami l i e  such as Apiaceae, Asteraceae, Lamiaceae ( Labiatae). Pinaceae, 
Pi peraceae, Rutaceae, and Zingiberaceae ( Ramawat et aI, 20 1 3; S i lvestre & 
Gandini ,  2008). 
Terpenes are most ly  hydrocarbon in  nature and their building block is  a five­
carbon isoprene unit (2-methyl- l ,  3 -butadiene) ( Figure 1 . 1 ) . I soprene was discovered 
by Wal lach in 1 887,  who defined the structure of most terpenes as the 'head-to-tai l' 
condensation of i soprene units ( Figure 1 . 1 )  which is  known as 'isoprene rule' 
(Christmann, 20 1 0) .  Therefore, terpenes can be c lassi fied according to the number of 
isoprene units with a molecular formula of (CSH8)n (n  is  the number of isoprene 
units). Accordingly there are monoterpenes, sesquiterpenes, d iterpenes, triterpenes 
and tetraterpenes with two, three, four, six, and eight isoprene units respectively 
(Aldred et aI, 2009). 
Isoprene 
(2-melhyl-1.3-butadiene) 
Hle ;/H2 
'"Head to Tan� monoterpene 
C-CH HC-C I II He HC-CH CH 
�ail to TaU- monoterpene 
Figure 1.1: Chemical strucrure of the Terpene . Isoprene const i tute the main bui lding block 
of terpene and can be found in e ither "head to tai l" or "ta i l  to tai l "  configurations (Blaber. 200 1 ). 
1 .2 Phy icochemical propert ies of  Monoterpenes 
Mo t monoterpenes are highly volat i le and non-polar ( l ipoph i l ic )  in nature 
which enables them part i t ion and dissol e in  cel lular membranes. They are colorless 
l iquid that are chemical ly  reactive and have characterist ic aromatic odors (Clarke, 
2008) .  Monoterpenes posses variable ba ic skeletons and also exhibit 
stereoisomeri sm ( Ramawat et al. 20 1 3 ) . Monoterpenes can exist i n  acycl ic structures 
such a myrcene. as wel l  as cyc l ic  tructures that could be monocyc l ic as (+)-
l imonene and dicycl ic as (- )-a pinene ( see Figure 1 .2 ). Moreover. there are a wide 
range of oxygenated derivatives (alcohols. aldehydes, ketones and carboxyl ic  acids)  
that can be deri ed from native basic skeletons ( Si lvestre & Gandin i ,  2008 ). These 
oxygenated fomls are known as terpenoids (Clarke. 2008 ) 
r� 6 2 2 2 � 
(-)-u-pincnc (+ )-hmoncne R( -)-a-phcllandrcne j olimonene Isotcrpinolenc 
myrccnc 
o 
�OH 
geranic acid 
�� - - -
O�OH 
neric acid 
Fioure 1.2: tructure of some cyclic and acyc l ic monoterpenes ( Heyen & I-larder, 2000) 
OH OH 
-� 
Camphor Carvacrol Carveol Carvone 
OH 2 0 � 
Linaloo1 Menthol Perillyl alcohol Pulegone 
1,8-Cineole Thymol Vanillin Eugenol 
Figu re 1.3: Structure of oxygenated terpenes (terpenoids) 
" -' 
1 .3 Bio logica l  activit)' of Monoterpene 
E ential o i l  hav e been used [or therap utic and cul inary purposes for 
centurie . e\ ral anc ient c iv i l i zations alued the therapeutic and medicinal effects 
of e sential o i l s  and uti l i zed tho e natural o i ls  for health promotion, veil -being and 
mental re laxation. Essential oil are complex mixtures and may possess a large 
p ctrum f biologi al act iv i t) many of them of c l inical interest . Many recent 
im eSligat ions [, cu ed on stud ing the biological effects of essential oils as a whole 
or. more recent ly ,  on their major isolated acti  e consti tuents i .e .  monoterpenes. 
These studies have found that monoterpene have al uable anti -oxidant, ant i-vira l ,  
anti -microbiaL anti -cancer, analgesic and ant i - in flammator effects ( for reviews, see 
A harya et aI, 20 1 0; C l i fford & DiG iovanni ,  20 1 0; de Cassia da i1veira e Sa et ai, 
20 1 3; Guimarae el ai, 20 1 3; Kamatou ef aI, 20 1 3; ostro & Papal ia, 20 1 2; 
S lameno a & Horvathova, 2013; Wagner & Elmadfa 2003 ) .  Some of these studies 
have been rev iewed in  the fol lowing sect ions.  
1 .3 . 1 .  Anti-ox idant activity 
Excessi e formation of react ive oxygen specIes ( ROS),  as a resul t  of 
exposure to environmental  factors l ike pol lutants and UV radiation, constitutes a 
major in i tiation factor in  the progression of many pathological condit ions. When the 
formation of ROS reaches beyond the capacity of cel lu lar antioxidant defenses, it 
leads to l ip id peroxidation and eventual l y  damages l ipid membranes, DNA bases and 
proteins ( Frankel & Neff, 1 983) .  Several studies demonstrated the potential 
antioxidant properties of s ingle or mult ip le monoterpenes ( for reviews, see Kozio l  et 
aI, 20 1 4; Porres-Marti nez et aI, 20 1 4; Raskovic et aI, 20 1 4; S lamenova & 
5 
r Ion alhova. 20 1 3 ) .  I n  a tud on the antiox idant effects of eucalyptus and cl ve oil , 
th)l1lol and eugenol (400 Ilg/ml), it has been shown that pure i olated monoterpenoid 
that x ists as a major const i tuent of these oils caused inhibit ion of the format ion of 
malonaldehye (product of l ipid oxidation) by 43 .3% and 5 7.2%, respectively ( Lee & 
hibamoto, 200 1 ) . I n  a later stud , the antioxidant potent ial of carvone, a-terpineol 
and perillyl alcohol was invest igated. Carvone showed maximum act ivi ty ( lCso 32 . 1 
gIL) that was 1 0  and 23 t imes greater than the act ivi ty of a-terpineol ( lCso 3 32 .8  
g/mL)  and perillylacohol ( lCso 738 .3  g/m L) (B icas et  af, 20 1 1 ) . Recent investigation 
of the antioxidant properties of i olated 11l0noterpenes in Spanish sage, a-pinene and 
1 ,8-cineole, demonstrated considerable protection of cells agai nst H202-induced 
oxidative stress. ROS production was signi ficantly inhibited by 1 ,8 c i neole ( 30-45% 
decrease at concentrations of 1 0  and 25 �lM)  ( Pones-Mart i nez et af, 20 1 4 ) . Further 
evaluation of the antioxidant act iv i ty of the individual isolated monoterpenes is 
needed for better understandi ng of their actions. 
1 .3.2.  Anti-i nflammatory activity 
I nflammation is associated with a cascade of biochemical events inc luding 
the formation of cytokines and inflammatory mediators that leads to inflammatory 
damage of t i ssues (for review Kemp et aI, 2008; Kovacs el aI, 1 994; Rosengren & 
Delves, 1 998) .  I n  the context of fi nding new natural ant i - inflanm1atory agents, 
essential oils and monoterpenes have been studied i n  several in vitro and in vivo 
models .  
In an earl ier study, 1 ,8-Cineole ( c ineole) demonstrated ant i - inflammatory 
act ivi ty when used orally in doses rangi ng from 1 00 to 400 mg/kg i n  d ifferent 
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in flammation models in rats ( antos & Rao. 2000) .  Another tudy by the same 
group. a monoterpene oxide, 1 .  8-cineole that e. i sts in several essential o i l s  \va 
eval uated for i t  ant i - in flammator act ivity usi ng the trini trobenzenesu lfonic acid 
(TNB )- induced col i t i  model in  rats ( antos et af. 2004) .  In  this study, both 200 and 
400 mg/kg do e of 1 ,  8-c ineole caused a sign i ficant decrease in gross colonic 
damage scores and wet weights of colonic segments of treated rats when compared 
with \eh ic le treated rats. This effect was evident only in rats that were pre-treated 
\\ ith this compowld but not the post-treated rats. 1 ,  8-c ineole also reduced 
myeloperoxidase act ivity and increased glutathione levels  ( Santos et af. 2004), 
suggest ing the potential value of this compound in preventing gastrointestinal 
i nflammation and ulcerat ion. 
everaJ studies reported an ant i - inflammatory effect of carvacrol ,  an aromatic 
c c l ic monoterpene that exists as a major consti tuent in the volat i le oil of thyme 
(Nabavi et aI, 20 1 5) .  I n  a recent study,( Hotta et aI, 20 1 0) i t  was found that 
carvacrol suppresses the act iv i ty of cycloxygenase-2 (COX-2), the rate- l imit ing 
enzyme in prostaglandin and other inflammatory mediator synthesis, through a 
mechanism i nvolv ing peroxisome pro l iferator-activated receptors a. and y ( P P  ARs). 
They showed that carvacrol can activate PP AR a. and y which in turn causes 
concentration dependent suppression of COX-2 expression (40% and 60% 
suppression by 200 and 400 flM carvacrol i ncubated for 24 hours) when exam ined in  
cel l -based transfection assays using bovine arterial endothel ial ce l ls .  I n  th i s  study 
( Hotta el aZ, 20 1 0), it was also shown that carvacrol caused suppression of 
l i popolysacharide-induced COX-2 m RNA and protein expression in macrophage-
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l i ke 93 7 cell . o l lect i  e ly these results indicate that monoterpenes have 
signi ficant ant i - in flammatory act i \  i t ies that might be of c l in ical value.  
1 .3.3. Ana lge ic act iv i ty 
Pai n has been reported to be the most common reason 
[or eek ing medical attention ( Ruoff, 2002) .  Di fferent classes of analgesic 
medicati n play a central role in the management of painful condit ions. However, in 
man) chronic pain cond it ions such as cancer and neuropathic pain .  current ly 
avai lable pam ki l lers are clearly insufficient for proper control of pain (Okuse, 
2007). A a result, th search for novel analgesic agents has been a major focus for 
discovery and development of new drugs. I n  this context, many monoterpenes have 
proven to be effective pain  rel ieving molecules in various experimental pain models 
( reviewed de ousa, 20 1 L Guimaraes et af, 20 1 3; Guimaraes et af, 20 1 4) .  Carvacrol 
is one of the monoterpenes that demonstrated clear antinoc icept ive effect using 
different pain  models (Cavalcante Melo et aZ, 20 1 2; de Santana et af, 20 1 4 ) .  
Carvacrol showed act ivati ng effects on P PAR a and 'Y which are known to  regulate 
the expression of COX-2 enzyme responsible for synthesis of mult iple pain  and 
i nflammatory mediators. I n  this study, carvacrol i nh ibited LPS- induced COX-2 
mRNA and protein expression in  human macrophage-l i ke U93 7 cel l s  (Hotta et aI, 
20 1 0) .  Furthelmore, carvacrol demonstrated anti-hypemocicept ive and anti ­
in flammatory properties when examined in mice using mechanical hypemociception 
models .  Systemic pretreatment with carvacrol ( 50  or 1 00 mg/kg; i .p . )  i nh ib i ted the 
development of edema and mechanical hypemoc iception caused by carrageenan and 
TNF-a. Besides this, carvacrol s ign ificantly decreased tumor necrosis  factor a (TNF­
a) levels in pleural lavage and suppressed the recrui tment of leukocytes without 
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affect ing the ir  morphology (Guimaraes et aI, 20 1 2b a) .  This  monoterpene also 
caused a signi ficant ant inocicept i \ e effect on formal in-. capsaic in- .  and glutamate­
induced orofacial nociception in mice (Guimaraes ef ai, 20 1 2a). Carvone is a 
monoterpene ketone that was pro ed to have antinocicepti e activity associated with 
decreased peri pheral nef\'e excitabi l i ty when investigated using writhing and 
fom1aJ in te t in mice (Goncalves el al. 2008). L inalool i s  one of the monoterpenes 
that was c learly reported to demonstrate anti nocicept ive propert ies using ariable 
experimental models.  Mult ip le reports sho\ ed that th is compound reduced pain  
sensat ion through modulation of muscarinic,  opioid, dopaminerigic,  adenosinergic 
and glutamatergic systems ( Bati sta e/ aI, 20 1 1 ;  Batista et ai, 20 1 0; Batista el aI, 
2008; Peana el aI, 2003;  Peana et aI, 2004a; Peana et af, 2004b; Peana el aI, 2006a; 
Peana et aI, 2006b). Other studies suggested the involvement of nicot in ic  receptors at 
the neuromuscular j unction ( Re el oZ, 2000) . Many other monoterpenes have also 
shown significant analgesic act ivi t ies, in several in vitro and in vivo pain  models  (de 
ousa, 20 1 1 ), suggest ing that monotepenes m ight be good candidates for analgesic 
drug development. 
1 .3.4. Ant imicrob ial  act ivity 
I t  i s  wel l  establ ished that some essential o i l s  have antimicrobial properties 
l ikely due to their function in most plants as a defensive mechanism ( Mahmoud & 
Croteau, 2002). Recently, there has been an increased i nterest in  essential o i ls  and 
their consti tuents as preservatives to prevent food-borne d iseases ( reviewed Burt, 
2004) .  The aromatic monoterpene carvacrol and various essential o i l s  containing 
carvacrol have been studied. Carvacrol demonstrated a wide spectrum of act iv i ty 
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again t many Gram-posi t ive and Gram-negative bacteria,  molds and yeasts 0 tro 
& Papal ia. 20 1 2 ) . In a recent study by Rivero-Cruz el al. (20 1 1 ). the antim icrobial 
propert ies of the es ential oil of Poliominrha longiflora and Lippia graveolen and 
the ir  major consti tuents were examined . Carvacrol showed better ant imicrobial 
act ivi t} than other components uch a thymol and p-cymene. Car acrol had a 
minimal inh ibitor) concentrat ion ( M IC )  of 1 28 Il g/ml compared to 256 to 1 024 
�lg/l111 M JC  value of th mol and p-cymene against various bacterial strains (R ivero-
ruz el aI, 20 1 I ) . Another stud i nvestigated the effects of essential o i l s  and its 
con t i tuents for prevention of oral infections ( Botelho el aI, 2007) .  Using the d isk 
d iffusion method, they sho\ ed that essential o i l  of Lippiasidoides and i ts major 
constituents, thymol and carvacrol ,  had sign i ficant antibacterial  and anti -candidal 
propert ies. Th; l110l  and carvacrol shO\ ed better i nh ibi tory effect compared to the 
essent ial oil in specific bacterial stra ins and Candida albicans. MIC values for the 
const i tuents ranged from 2.5 to 5 . 0  mg/ml whi le MIC for the o i l  ranged from 5 to 1 0  
mg/ml ( Botelho el aI, 2007) .  M in imum fungicidal concentration of carvacrol was 2 .5  
mg/ml whi le  thymol showed s imi lar act iv i ty to the essential o i l .  M inimum 
bactericidal concentration of the essential o i l  was 20-40 mg/ml whi le it was 5 .0 
mg/ml and 1 0  mg/ml for carvacrol and thymol respective ly ( Botelho et aI, 2007). 
Col lectively, these studies emphasize the potent ial  for uti l iz ing essentia l  oi ls and 
monoterpenes as antimicrobial agents or adj uvant to conventional treatment .  
1 .3.5. Ant i-carc inogen ic  activity 
Cancer i s  a chronic process characterized by abnonnal cel l  pro l i feration and 
d ifferentiat ion. Chemoprevention is a phannacological approach to arrest or reverse 
the process of carc inogenesis mainly by inhibi t ing enzymes or receptors of chemical 
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mediat rs that play an important role e pecia l l  during the in i t iation and progression 
phases. Chemotherapy main ly involve i nhibi t ion of tumor cel l  pro l iferation and 
enhanc ing apoptosi ( porn & uh, 2000) .  There are many studies report ing that 
some monoterpenes how either chemopreventive or chemotherapeutic effects. For 
e 'ample, in a study in e t igating anticancer act iv i ty of thymol using peripheral 
blood mononuc lear c J I ( PBMC)  and promyeJotic cancer cel l  l i ne HL-60, i t  was 
hown that thymol has do e dependent cytotox ic effects on H L-60 cel ls after 24h of 
exposure starting from 25�M.  1 10\\ ever, thymol did not show any cytotoxic effect i n  
nomlal human PBMC up  to 48 hours of  exposure ( Deb e t  aZ, 20 1 1 ) . I n  a s imi lar 
study exploring the apoptot ic potential of d- l imonene in two human leukemia cel l  
l i nes ( K562 and H L60 cel l l ines), i t  was shown that d-Limonene induced apoptosis 
in a dose-dependent manner start ing from O. l mM up to 0.8 mM with s imi lar potency 
in both cel l l ines (J i  et aI, 2006). The anti carcinogenic actions of various 
monoterpenes have been further di scussed in recent reviews ( Bhal la e/ aI, 20 1 3 ; 
Gautam et aZ, 20 1 4; Sobral e! aI, 20 1 4 ) .  
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1 ...1 .  Effect on M onoterpene on Di fferent I on Chan nel and Receptor 
Ion channels are integral m mbrane proteins that control passage of charged 
ions ( a ,  K+-. a2+-, or C Il through the cel l ' s  l i pid bi la er. pening and clo i ng 
(gat ing) of the e channels  can be contro l led by membrane voltage, l igand binding, 
stretch, or other physical stimul i .  ny  of  these e ents deforms the channel protein 
affecting i ts conformation lead ing to opening of the gate and ion permeat ion ( for 
revie\ s see Cannon e/ aI, 20 1 4 ; Tien et aI, 20 1 4 ; Weir 20 1 3 ; Wu & Cui ,  20 1 4) .  
Activity of ion channels  underl ies the fundamental basis of cel lular exci tabi l i ty, 
mu cle contraction. neurotransmitor release, exc itation transcription coup l ing, 
honnone secretion, and other transmembrane signal ing processes (Cannon et ai, 
20 1 4 ; Tien e/ ai, 20 1 4). Many drugs exert thei r  therapeutic effects by act ing on the 
ion channels of various excitable and non-exci table cel ls .  Many phytochemicals have 
provided opportunit ies for development of new med ications. In this context the 
effects of monoterpenes have been recent ly  i nvestigated on the nmctional propert ies 
of various ion channels  (de Araujo et ai, 20 1 1 ) . The resul ts of some of the recent 
studies wi l l  be reviewed in the fol lowing sect ions. 
1 .4 . 1 .  Sod i u m  channels 
Voltage-gated sodi um channels are important for in i t iat ion of action 
potentials in  neurons, muscle, and other exci table ce l ls .  Sodium (Na+) channe ls  are 
act ivated when membrane depolarization i nduces conformational changes i n  the 
channel structure leading to openi ng of the pore al lowing sodium influx .  Local 
anesthetic,  antiepi lept ic,  and antiarrhythmic drugs bind to a receptor s i te within the 
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pore of the a channel and block it, ,,\ hereas many c lasses of neurotoxins bind to 
di  t i nct receptor ite and alter sod ium channel function (Cattera l l  el ai, 20 1 3 ). 
In an earl ier tud) ( Hae eler el ai, 2002), the effect of thymol and menthol 
were evaluated on whole cel l sodium inward cur ents via heterologously ( H E K293 
cel l ) expressed rat neuronal and human skeletal muscle sodium channels .  odium 
currents were inhibi ted with hal f  maximal concentration ( IC50) values of 1 04 and 1 49 
IJ.M for thymol and 3 76 and 57 1 IJ.M for menthol for the skeletal musc le and the 
neuronal a + channel ,  respect ively. The blocking potency of both compounds 
increased at depolarized holding potentials ( Haeseler et ai, 2002) .  The results of this 
study suggested that the antinoc iceptive and local anesthetic effects of thymol and 
menthol may be mediated via blockade of Na+ channels .  In agreement with these 
results, Gaudioso et a I . ,  (20 1 2 ) examined the effect of menthol on vol tage-gated Na+ 
channels in  dorsal root gangl ion ( DRG) neurons. By use of a patch c lamp the effects 
of menthol appl ication were evaluated on tetrodotoxin (TTX)-resistant Nav 1 . 8 and 
Nav 1 .9 channel subtypes in DRG neurons, and on TTX-sensi t ive Na+ channels in  
immortal ized DRG neuron-derived F l l cel ls .  The results indicated that menthol 
inh ibited vol tage-gated Na + channels i n  a concentration, voltage, and frequency­
dependent manner. Menthol promoted fast and slow i nactivation states, causing use­
dependent depression of Na + channel act iv i ty (Gaudioso et ai, 20 1 2 ) .  In current 
c lamp recordings, menthol i nhibi ted firing at h igh-frequency stimulation with 
min imal effects on normal neuronal act iv i ty .  Furthermore i t  was found that low 
concentrations of menthol cause analgesia in mice, re l ieving pain  produced by a Na+ 
channel-targeti ng toxin .  I n  th is study, i t  was concluded that menthol i s  a state 
selective blocker of Nav 1 .8 ,  Nav 1 .9, and TTX-sensi t ive Na+ channels, i ndicati ng a 
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role fur a chann I blockade in the efficacy of menthol as a topical analgesic 
compound (Gaudio 0 el aI, 20 1 2 ) .  
Recently, t\\ O groups, inve t igated the effect of carvacrol and related 
monoterpene n a + channel of mammal ian (Goncalves el aI, 20 1 0) and vertebrate 
(Kawasaki er aI, 20 1 3 ; Matsushita el ai, 20 1 3 )  neurons. Goncalves el aI. , ( 20 1 0) 
im cstigated the effects of (+)  and ( - )-carvone, carvacrol, carveo l, and l imonene on 
compound action pot ntial (C P )  characterist ics using a mod ified s ingle sucrose-gap 
method . It was demonstrated that ( -)-carvone wa less potent ( ICso= 1 0. 7  mM) in  
reduc ing nerve exc itabi l i t  than i t s  enantiomer, (+)-carvone ( lCso=8.7 mM) .  In a 
tructure-activity relat ionship study, i t  was demonstrated that hydroxyl groups in the 
carveol and carvacrol molecules enhanced the CAP blocking-effect, whi le the 
ab ence of the oxygen moiety in l imonene resul ted in the effect bei ng almost 
abol ished. In another study ( Kawasaki ef aI, 20 1 3 ), it was shown that ( -)-menthol 
and (+)-menthol concentration-dependent ly reduced CAP peak ampl i tude with ICso 
values of 1 . 1  and 0.93 mM, respectively. However, other monoterpenes such as p­
menthane, l imonene and menthyl chloride at 7- 1 0  mM min imal ly affected CAPs. On 
the other hand, ( -)-menthone, (+ )-menthone, ( - )-carvone, (+ )-carvone and ( -)-carveol 
and pulegone inhibi ted CAPs with potencies s imi lar to that of menthol ( Kawasaki et 
aZ, 20 1 3 ) .  In another study by Joca and his co-researchers (Joca et al 2012), 
carvacro l ' s  effect was tested on CAP in i solated rat sciatic nerve. In agreement with 
previous reports, carvacrol reversibly blocked the excitab i l i ty of the rat sc iatic nerve 
in a concentration-dependent manner with an I Cso value of 0 .5  mM. Also, carvacrol 
blocked the generation of action potentia ls  ( ICso= 0.36 m M )  of the i ntact DRG 
neurons without altering the resting potent ia l  and i nput resistance ( Joca et aZ, 20 1 2).  
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Furthermore. can acrol reduced the \ol tage-gated a + cun'ent of dissociated DRG 
neuron ( l  50= 0.37 mM).  In conc lusion the e stu die demonstrated that carvacr I 
blocks neuronal excitabi l ity b) d irect inhibit ion of the voltage-gated a+ current 
sugge t ing that this compound can act a a local ane thet ic .  
Eugenol, a m noterpenoid widely used in dentistry for it anesthetic 
properties. \\  as investigated for its effect on oltage-gated a + channels (Cho ef aI, 
2008: Park ef al. 2006) .  Cho el at demonstrated that an inhibitory effect of eugenol 
,,, as evident for both TTX- ensitive and TTX-resistant Na+ channels in rat DRG 
neuron . The Ko values were 308 IJM and 543 IJM for TTX-sensit ive and insensit ive 
a+ channels, re pect ively. Eugenol did not infl uence the act ivation voltage of ei ther 
type of odium current. However. eugenol moved the steady-state inactivation curves 
of both a+ currents to a hyperpolarizing direction and reduced the maximal Na+ 
current (Cho et al. 2008) suggesting that eugenol i nh ibi ts sodium currents by 
interacting with resti ng and inactivated channels. The recovery from inact ivation of 
both a+ currents was slo\ ed by eugenol .  But, the eugenol inhibit ion of Na+ currents 
was not dependent on the st imulus frequency. In another study, using a whole-ce l l  
patch-c lamp technique, the effect of eugenol was tested on voltage-gated sodium 
channel s  in  rat dental primary afferent neurons ( Park ef ai, 2006). Eugenol i nh ib i ted 
action potentials and two types of Na+ currents; TTX-resistant and TTX-sensit ive. 
Another group (Moreira-Lobo et aI, 20 1 0) examined the effect of eugenol on action 
potentials recorded intrace l lu larly from rat superior cerv ical gangl ion ( SCQ). They 
showed that eugenol caused reversible, concentration-dependent blockage of action 
potentials with an ICso of 0.3 1 mM ( Moreira-Lobo et ai, 20 1 0). The results of these 
1 5  
studi s ugge ted that inhibit ion of Na + current can be considered as one of the 
mechanism bJ v, hich eugenol exert analgesia. 
In  DR neuron, another monoterpene. l inalool reduced the amplitude of 
action potent ials in a reversibl and concentrat ion dependent manner with an lCso of 
l . 85 m 1 ( Leal-Cardo 0 et ai, 20 1 0). Linalool al 0 i nhibi ted excitabi l ity of the 
sciatic nen e with an I 50 of 0.78 mM ( Leal -Cardoso el ai, 20 1 0) .  In this study, it 
wa also ho\\n that l inalo0 1 ,  in the concentrat ion range of 0. 1 to 6 mM, reversibly 
bl cked the generation of action potentials in  intact DRG neurons and inh ibited the 
odium current of di ssociated DRG neurons ( Leal -Cardoso et ai, 20 1 0) .  I n  another 
tudy lIsing newt o lfactory receptor cel l s ,  l i nalool i nhibited voltage-dependent Na + 
currents \\ i th an IC -o 0[ 0.56 mM (Narusuye el af, 2005) .  
1 ..4.2 Calc i u m  channels 
Voltage-gated Ca2+ channels are responsible for contro l l ing Ca2+ influx 
through the p lasma membrane. Entrance of extrace l lu lar Ca2+ through these channels 
is  crucial for many physiological functions of excitable cel l s  such as neurons and 
various types of muscle .  The structural di ersity of Ca2+ channels is related to their 
function in different tissues, such as neurotransmi tter release from nerve endings 
cardiac and smooth musc le contract ion, Ca2+ -dependent modulation of enzyme 
act ivity and gene transcription (Reuter et aZ, 20 1 3 ) .  
In  ear ly studies, several monoterpenes have been shown to  modulate the 
functions of voltage-dependent Ca2+ channels. Among these monoterpenes, menthol 
has attracted much interest. H igh-potassium induced Ca2+ increases in Leech neurons 
(Dierkes et aZ, 1 997), synaptosomes and chick ret inal  neurons (Hawthorn et af, 1 988) 
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have been hOWD to be uppre sed b .. menthol . Menthol i nhibi ts K+ depolarization­
induced and electrical ! )  t imulated re pon es in i leum, and atrial and papi l l ary 
muscles. I 50 valu s in the i l eac preparation ranged from 7 .7  to 28 . 1 J-lg/ml and in 
the cardiac preparation from 1 0 . 1  to 68.5 J-lg/m l .  Furthermore, both menthol and 
peppennint o i l  competit ively inhibi ted speci fic binding of eH ]n itrendipine and 
eH ] p 200- 1 1 0  to mooth and cardiac musc le and neuronal preparations with 
potencies comparable to those measured in pharn1acological experiments ( Hawthom 
el 01, 1 988) .  In another tudy ( idel l et aI, 1 990), brief exposure of LA- -5 cel l s  to 
menthol decreased the depolarizat ion-induced ci+ i nfl ux though both 
d ihydropyrid ine ( DH P)-sensit i  e and DH P-insensi t ive channels. The effect was 
concentration dependent with ICso value of 0.25 mM,  rapid in  onset and readi ly 
reversible. I n  a recent stud , in  agreement with earl ier results, menthol has been 
shown to induce relaxat ion and i nhibit contract ion in rat aorta, mesenteric and 
coronary arteries, primari ly through inh ibi t ing Ca2+ influx via n i fedipine-sensit ive 
Ca2+ channe ls  (Cheang et aI, 20 1 3 ) .  Simi larly, the resul ts of another study indicated 
that menthol (0 . 1 -30 mM) i nduced spasmolytic effects in human colon c ircular 
muscle inhibiting contracti l ity of the gastrointestinal smooth muscle, by blocking 
Ca2+ i nflu.x through L-type Ca2+ channels (Amato et ai, 20 1 4) .  Simi lar results have 
also been reported in bronchial smooth musc le (Wright et aI, 1 997) where menthol 
caused relaxation of KCl  and ACh preconstricted bronchi in vitro. 
I n  addit ion to functional studies, there have also been electrophysiological 
i nvestigat ions. The effects of menthol (0 . 1 -0.5 rnM) on Ca2+ current i nact ivation was 
studied i n  Hel i x  neurons ( Swandul la  et 01, 1 986). External ,  but not i nternal ,  
app l ication o f  menthol accelerated the Ca2+ -dependent rapid phase of inactivation. 
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Later. the effect of menthol on vol tage-dependent Ca2+ currents \-\ as investigated in 
cultured dorsal root gangl ion cel l from chick and rat embr, os ( Swandul la  el aI, 
1 987) .  Appl ication of menthol (0. 1 - 1  mM) had d ifferent effects on the various types 
of a2+ current in th se n urons. Below -20 m V, the 10\ thre hold Ca2+ CUlTents 
were reduced in ampl i tude in a dose-dependent manner by menthol with l i t t le effect 
on their activation kinetics. In  contrast, the t ime course of inactivation of the high­
threshold CaL+ currents, activated above - 20 m V from a holding potential of - 80 
m V. wa dra tica l ly  accelerated by external menthol .  The action of menthol was 
unchanged with more posit ive holding potent ia ls ( -50 mY) .  I mportant ly ,  menthol 
exerted its action only when applied from the outside. Col lectively, the resul ts of 
these studies indicated that menthol b locks Ca2+ currents through the low voltage­
acti ated Ca2+ channel , and faci l i tates inactivation gating of the c lassical h igh 
voltage activated Ca2+ channel .  Recently, Bay l ie and his group investigated the 
actions of menthol on L-type Ca2+ currents in rabbit ventricular myocytes at near­
physiological temperature (-35°C)  using whole-ce l l  recording ( Bayl ie et aI, 20 1 0) .  
MenthoL concentration-dependent ly i nhibited peak Ca2+ currents ( ICso=74 .6) .  In 
addition, menthol b locked the late CUlTents remaini ng at the end of depolari sing 
pulses with greater efficacy (96. 1 % block at 1 m M )  than peak Ca2+ currents (68.9 % 
block at 1 mM)  ( Bayl ie  et ai 20 1 0) .  
In cardiac muscle, other monoterpenes have been shown to modulate the 
function of L-type Ca2+ channels .  The negative i notropic effect of Pulegone was 
investigated in guinea pig atria (de Cerqueira et ai, 20 1 1 ) .The effects of pulegone 
were compared with n ifedipine, a wel l -known L-type Ca2+ channel blocker, and 
pulegone showed a simi lar pattern of concentration-dependent inhibit ion of atrial 
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contrac.t i l i t)  t that f n i redipine with much lower potenc) . onc ntration-re pon e 
cun e demonstrated an I �() of pulegone of 777I1M c mpared to 1 . 1  11M � r 
�, 
J1 I fcuip1 l1e. 1 0  e\.plore the im oh ement of L-t) pe Ca- channel in  the negative 
inotropic effect'  l' pulegone. they used the elective L-t)pe Ca2+ channe l  agoni t ,  
BA Y K8644. In the e, periment , upon preincubat ion with 3 . 2  mM pulegone, the 
r ,0 of B,\ Y K8644 increa ed ign i ficantl from 0. 1 11M to 0.6 11M .  To further 
con linn the role of L-type Cal channels, whole-cel l  pat h c lamp experiment were 
prefelTcu in i o lated mouse \ entricular myocytes expo ed to pulegone (de erqueira 
e( al. 20 1 1 ) .Pulegone cau ed a reversibl  inhibi tory effect on peak L-type Ca2+ 
current. In another 'et of experiment , u ing isolated cardiomyocytes pre-loaded with 
the intracel lu lar Ca2+ indicator F lu04-AM, the effect of pulegone wa examined on 
global Ca2+ tran ient .The cel ls  were electrical ly  st imulated to record intrace l lular 
a2+ tran ients. The re ults. consistent with the previous findings, indicated that 
pulegone. concentration-dependentl , reduced i ntracel lular Ca2+ transients (de 
Cerqueira et al. 20 1 1 ) . 
U ing the whole-cel l  configuration of the patch-clamp technique. thymol ( 1  
�l i- I mM range), i nh ib i ted peak ampl i tude of L-type Ca2+ current i n  G I 08- 1 5  
cel l s  (Huang el al. 2005) and rat skeletal musc le fibers (Szentandrassy el af, 2003) 
and ventricular cardiomyocytes (Magyar et aI, 2002) .  imi lariy, i n  isolated cardiac 
m)ocyt s. both eugenol ( ensch el aI, 2000) and carvacro l  (Magyar el al. 2004) 
caused i nhib ition of peak L-type Ca2+ currents with IC50 of 226 11M and 98 11M ,  
respectively .  Eugenol was also examined o n  cloned T-type Ca2+ channel isofonns 
expressed in HEK293 cel l s, using whole-cel l  patch c lamp. In th is  study, eugenol 
caused i nh ibition of Cav3 . 1 ,  Cav3 .2, and Cav3 .3  currents in a concentration-
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dependent manner ( eo el ai, 20 \ 3 ) .  nother recent tudy ( Peixoto- eves el aI, 
20 1 4 ) demon trated that eugenol di late arteries in a concentrat ion-dep ndent 
manner and inhibit vol tage-dependent Ca2+ currents i ll isolated cerebral artery 
smooth muscle cel ls .  nother monoterpene, l inalool has also been shown to suppress 
voltage-gated a2+ current in retinal horizontal cel ls  and Purk inje  cel l s  (Narusuye et 
0/, 2005). Col lecti"ely, these findings uggest a sign i ficant inhibitory act ion of some 
monoterpenes on L-type Ca2+ hannels and may provide a structural template for the 
de\elopment of new L-ty pe a2+ channe l  blockers. 
1 .4.3. Pota i U I11 channels 
Voltage-dependent K+ channels are activated by changes i n  membrane 
potential and function to repolarize the membrane potent ial and function to 
repolarize the membrane potential to resting levels by sel ectively al lowing passage 
of K+ ions down its e lectrochemical gradient across the cel l membrane.  Voltage­
dependent K+ channel s  are widely distributed in mammal ian t i ssues and p lay 
important physiological roles ( for recent reviews, see Gonzalez et aZ, 20 1 2 ; Jan & 
Jan, 20 1 2; erbonne, 20 1 4; Oudit et ai, 2004). The functional roles of voltage­
dependent K+ channe ls  inc lude setting the durat ion of action potentials and the 
interspike i nterval during repetitive firing in neurons and in the heart, secreting K+ in  
epithe l ia  and adjusting the contract i le tone of the smooth muscle .  Voltage-dependent 
K+ channel s  consist of four subunits. The tremendous d iversity of voltage-dependent 
K+ channels can be attributed to the large number of d ifferent genes present, 
aux i l iary �-subunits and metabol ic regulation (Latorre et aZ, 20 1 3) .  
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There are ery fe\, tudie explori ng the effect of monoterpenes on voltage­
dependant K+ channel . [hy mol had an inhibi tory effect on transient oun ard 
rota sium current in a concentration-dep ndant manner in canine and human 
\ entricular myocytes (Magyar el ai, 2002). Thymol caused inhibit ion of K+ currents 
"" i th an E :0 of 60.6 IlM, howe er, the kinetic of K+ currents were not much altered 
by thymol .  The ffect de e loped rapid ly  (within 0.5 min) and were readi ly  
reversible (Magyar ef  01, 2002) .  S imi larly inh ibi tion of K+  current by  thymol has also 
been reported in skeletal mu c le fibers ( zentandrassy el 01, 2003) .  Another study 
using whole-ce l l  patch c lamp reported that eugenol also inh i bits vol tage-gated K+ 
curr nts in rat trigeminal gangl ion neurons and human Kv 1 . S currents stably 
expressed in Ltk( - )  cel ls in a concentrat ion-dependent and reversible manner ( Li et 
ai, 2007). In addition to voltage-dependent K+ cUlTents, ci+ -activated K+ CUlTents 
have also been shown to be modulated by monoterpenes. For example, Ca2+­
activated K+ channels were activated by menthol in human gl ioblastoma cel l s  
(Wondergem & Bart ley, 2009) and by thymol in  pitui tary G H 3  cel l s  (Huang et ai, 
2005) .  
1 .4 ..1.  Non-selective cation channels 
Transient Receptor Potential chamlels (TRP channels) are a group of non-selective 
cation channels .  The founding member of this fami ly  was discovered in Drosophila 
and divided into six subfami l ies, named C, V, M ,  A, P, and M L, on the basis of 
amino acid sequence homology: canonical ,  van i l loid, melastati n, ankyrin repeat, 
polycystins, and mucolipins, respective ly  (Clapham & Squire, 2009) .  TRP channels 
function as cation channel s  that mostly  increase intracel lular Ca2+ levels .  However, 
only a few of the T RPs are highly Ca2+ selective, and exhibit a variety of gat ing 
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mechani ms. The) are activated b variable st imul i  l ike changes in temperature. pH.  
and 0 molarit) . and are modu lated b) gro\\-1h factor and G-protein-coupJed receptor 
pathways. The e channels are in o lved in diverse physiological proces e , such as 
photoreception, pain percept ion. mechanosensation them10 ensat ion, cel l  growth, 
secretion, and ion channe l regulation (Freichel & Flockerzi, 2007). 
A major d ifficult) in the tudy of TRP channels is  the lack of spec ific 
phamlacological agents that modulate 1110st members of the TRP superfami ly .  
everthele , exploring the effect of d i fferent 1110noterpenes has recently been a 
highly attractiw area for re earchers in  this field .  everal reports screened the 
activity of a wide range of structura l l  related monoterpenes on selected TRP 
channel subtypes. One of these studies focused on TRPV3, a thermo sensit ive ion 
channel expressed predominantly in  the skin and neural t issues, and screened a 
selection of monoterpenoid compounds using whole cel l  patch c lamp techniques. 
Monoterpene camphor i s  a known agonist of TRPV3 (Moqrich et aI, 2005) .  Out of 
33 screened compounds, s ix monoterpenes sign ificantly more potent than camphor, 
were identified : 6-tert-butyl-m-cresol (290%), carvacrol (265%), dihydrocarveol 
(255%), thymol (245%), carveo] ( 1 50%) and borneol ( 1 1 8%). Dose-response cur es 
for these six compounds were determ ined using voltage clamp techniques in TRPV3 
expressing Xenopus leavis oocytes. Their ECso values were found to be up to 1 6  
t imes lower than that of camphor ( Vogt-Eisele et aI, 2007). Another study examined 
the effect of thymol and other related compounds on human TRP A 1 channels, a TRP 
channel subtype that i s  known to respond to noxious cold (Story et aI, 2003) .  
Thymol (6 .25 and 25 JlM)  caused depolarizat ion of HEK293 cel l s  expressing 
hTRP A l  determ ined by a strong i ncrease in  dye fluorescence using a Ca2+ imaging 
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a af . I Ilnamaldehyde. a a posit ive control ,  howed a simi lar profi le and both 
compounds h \\'ed no activity on the parental HEK293 cel ls ,  indicating spec ific 
a t i \ it) on hTRP 1 channe ls  ( Lee et aI, 2008 ) .  In the arne tudy, the direct effects 
of th mol on TRP I mediated currents \ ere tested using whole-cel l  ol tage clamp. 
Thymol activated TRP A 1 current with an EC·o of 1 27 11M, but this activation was 
eliminated upon repeated appl ication of thymol due to channel desensi t izat ion. 
Desensitization by thymol reduced the response to A IT C  (al lyl i othiocyanate, a 
known agonist), indicat ing that both compounds act on the same channels ( Lee e/ aZ, 
2008) .  
In an  attempt to  identify the pharmaco logical mechanism of its 
antinociceptive effect, actions of carvone \i ere examined using DRG neurons and 
TRPV l -expressing HEK293 cel l s  in Ca2+ imaging experiments. I n  this study 
carvone stimulated a signi ficant increase in intrace l l ular Ca2+ levels  (Goncalves et aI, 
20 1 3 ) .  This increase in cytosol ic  Ca2+ level was complete ly abol ished when cel ls 
were preincubated with Ca2+-free bath solution, S 11M ruthemium red (non-specific 
antagonist of TRP channels) and 1 0  11M of capsazepine ( spec ific  TRP V  1 
antagonist), confirming that the effects of carvone were mediated by TRPV 1 
activation ( Goncalves et aZ, 20 1 3) .  Col lectively, these results suggest that 
monoterpenes can be useful for the development of new drugs i nvolving TRP 
channel-related pathological condi t ions. 
1 .4.5. GABA and G lycine receptors 
Receptors for ),-amino butyric acid (GABA) and glycine (G ly)  are pentameric 
l igand-gated ion channels that respond to inhibitory neurotransmitters by opening a 
chI ride- elective central pore ( t in ier el 01, 20 1 3 ) .  G BA i the maj r inhibitory 
neurotransmitter in the entral ner ous y tern. GABA i s  s nthesized in  GABAergic 
neurons and released in the naptic cleft in re ponse to an action potent ial . Upon i ts 
relea e, GAB act at two di fferent t pes of receptors: the ionotropic 
GABA..\ receptor (chloride-selective Ion channels) and the metabotropic 
GAB B receptor CG-protein coupled receptors) .  In case of GABA receptor, 
binding of GABA triggers a con formational change in the receptor leading to the 
opening of the pore. This causes a state of hyperpolarizat ion and therefore neural 
suppression (M inier ef 01, 20 1 3 ) .  Glycine receptor are found predominantly in the 
spinal cord and brain stem. G lyc ine re leased from nerve endings act by binding to 
the glycine receptor (GlyR) and cause opening of chloride charmels leading to 
hyperpolarization and subsequent neural suppression (Ashcroft, 2000). 
Severa! monoterpenes have been used in  conventional medic ine as anesthetic 
and anxiolyt ic agents (Bakka l i  et aZ, 2008; Denner 2009) .  These effects of 
monoterpenes lead to the i nvestigation of these compounds on GABA and glycine 
receptors. Among the monoterpenes, the effect of menthol on GABA current was 
extensively studied by d ifferent groups of researchers using various in vitro and in 
vivo models. In an earl ier study screening the effects of monoterpenoid alcohols and 
ketones on recombinant human GABAA (a l  �2y2s) and glyc ine  (a l homomers) 
receptors expressed in Xenopus oocytes, GABA-induced currents were enhanced by 
coappl ication of 1 0-300 �M of monoterpenes in the fol lowing order, (+)-menthol > 
( -)-menthol > borneol > menthone = camphor = carvone ( Hal l  et af, 2004). However, 
appl ication of menthol alone ( up to 1 mM) did not induce direct current indicating no 
agonistic activ i ty of menthol .  Menthol, 1 00 �M, reduced ECso values for GABA and 
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glycine from 82 to 25 flM and from 98 to 75 flM respect ivel , indicating that 
menthol act a a po it iv modulator of G BA and glycine inh ibitory currents ( Ha l l  
el  (II. 2004). In contrast to menthol .  appl ication of diastereomers of thujone inhibi ted 
GABAA receptor cunent . imi larly, another group of researchers i nvest igated the 
effect of menthol and other monoterpenes in Xenopli laevi · oocytes expressing 
ABA\ receptors ( Watt el ai, 2008). They found that upon co-appl icat ion of sub­
maximal (EC20) GABA concentrations, the cunent sizes were enhanced 
concentration-dependent ly in the fo l lowing order: (+)-menthol (e .g. by �2-fold at 50 
flM ) > isopulegol > i omenthol > a-terpineol » cyc lohexanol (Watt el aI, 2008). In  
thi study. they also compared the effect of (+)-menthol to c l in ical ly  used anesthetics 
such as propofo! .  At 2 �LM prepofol and 50 flM (+)-menthol ,  the level of GABA 
EC20 current enhancement was almost s imi lar ( 1 1 9% and 96.2%, respectively) .  
When co-appl ied. currents directly activated by 50 flM propofol were sign ificant ly  
inhibited (up to 26%) by 50 f lM (+)-menthol suggesting that menthol and prepofol 
compete for a common binding site on GABAA receptors. I n  an in vivo tadpole assay 
(based on using gradually increasing concentration of the anesthetic agent and 
exan1i ning loss of righting reflex of the tadpole)  addition of (+)-menthol resul ted in  
an anestheti c  effect with an EC50 of 23 .5  flM (� 1 0-fold less potent anesthesia than 
propofol)  (Watt et aI, 2008) .  In radiol igand binding experiments, it was found that 
only (+)-menthol ,  among the five stereo isomers analyzed, was active, stimulating the 
binding of eH ]-flunitrazepam, an a l losteric GABAA receptor l igand, i n  a dose­
dependent manner (Corvalan et ai, 2009). I n  another radiol igand binding study in  
housefly head membrane preparat ions, specific  binding of eH] ­
tbutylbicycloorthobenzoate (TBOB), a non-competit ive inhibitor of picrotoxin, was 
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enhanced b, 1 ,8- ine Ie, carvacrol ,  citr nel l ie  acid, puJegone and thymol .  On the 
other hand. four monot rpenoid , camphor, menthol ,  safrole and vani l l in. 
significantl) inhibited the eH J -TBOB binding (Tong & Coats, 20 1 2 ). 
;-\nother stud) sho\''v ed that menthol reduced the excitation of cultured rat 
hippocampal neuron and suppressed the epi leptic activity induced by 
pent) lenetetrazole injection and electrical k ind l ing in vivo (Zhang el ai, 2008) .  I t  was 
found that menthol not only enhanced the currents induced by low concentrations of 
GAB but also direct ly acti ated GABAA receptors in hippocampal neurons in  
cul ture. Furthermore, in  the CA l region of rat hippocampal s l ice , menthol enl1anced 
ton ic GABAergic inhibit ion al though phasic GABAergic i nh ibit ion was unaffected . 
Another study examined the effects of menthol on respiratory rhythm generation in  
brainstem-spinal cord preparations isolated from newborn rats (Tani el  aI, 20 1 0) .  
The results suggested that menthol has potent i nl1 ib i tory action on burst generation of 
pre-inspiratory neurons due to direct activation of tonic GABAA channels by 
menthol .  I n  another recent invest igation, the actions of menthol on GABAA receptor­
mediated currents in intact midbrain sl ices were exanl ined ( Lau et al, 20 1 4) .  Whole­
cel l voltage-clamp recordings in  periaqueductal grey (PAG) neurons in midbrain 
sl ices were used to determine the effects of menthol on GABAA receptor-mediated 
phasic inhibitory postsynaptic currents ( I PSCs) and tonic currents ( Lau ef aI, 20 1 4 ) .  
Menthol ( 1 50-750 11M)  produced a concentration-dependent prolongat ion of 
spontaneous GABAA receptor-mediated I PSCs, but  not non-N-Methyl -D-Aspartate 
(NMDA) receptor-mediated currents. Menthol act ions were unaffected by TRPM8 
and TRP A 1 antagonists, tetrodotoxin and the benzodiazepine antagonist, flumazen i l .  
Menthol also enhanced a tonic current, which was sensitive to the GABAA receptor 
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antagonist ·. picroto'\in and bicucul l i ne .  The e resu lt ugge ted that menthol 
posit i\ e1y modulate both ) napt ic and extra ,) napt ic populati n of G B \ 
rl.!ccptors in nat i\"e neurons I' 
Th} mol i another mon terpene that ha been te ted on GAB , receptor . 
One group u ed primaT} ulture or cortical neuron to examine the effect of th) mol 
on nal i\t.� GABA \ re eptor (Garcia el ai, 2006). They howed that thymol nhanced 
GAI3 .\- indueed chloride in flu'>: at concentrat ions lower than tho e exhibit ing direct 
aet l \  it} in the ab ence of ABA and that th) mol i a posi t ive a l lo teric modulat r of 
G \B \ receptor a i t  enhanced eH] flunitrazepam binding with an E 50 = 1 3 1  11M .  
I nterest ingly. both bicucul l ine, a competiti e GAB receptor antag ni t, and 
picroto,in, a non-compet itive antagonist, were able to completely inhibit this 
increa 'e in eH ]flunitrazepam binding induced by th mol . The thymol structural 
analogues menthol and cymene, which lack an aromatic ring or a hydroxyl group, 
did not affect eH ] flunitrazepam binding (Garcia el ai, 2006). 
In another inve t igation ( Reiner el ai, 2009), researchers detenni ned and 
correlated everal l ipophi l ic parameters for GABAergic agents and three other 
related phenol ic  monoterpene (eugenol, carvacrol and chlorothymol ) .  The resu l ts of 
their correlation studies demonstrated the h igh capac ity of these monoterpene to 
interact with phosphol ipid membrane phases, which can be predicted by 
physicochemical parameters such a 10gP(o/\\). F inal ly ,  the fact that all monoterpenes 
studied were able to interact with membranes suggested that some a l teration of the 
GABAA receptor l ipid environment can be exerted by thymol and other phenol ic 
compounds ( Reiner et  aI, 2009). In another study (Reiner el aI, 20 1 3b),  researchers, 
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u ing Langmuir fi lm , analyzed the effects of  thymol on  the molecular properties of 
the membrane . I I  th compounds studied v ere able to e pand pho phol ipid fi lms, 
by their incorporati n into the monolayer membranes. Epi fluorescence image 
revealed th pre en of  monoterpene bet\ een pho phol ipid molecules, probably at 
the head-group region. The re ult  of thi tudy indicated that the thymol and other 
phenol stud ied w re able to interact ith membranes, suggesting that their 
bi logi al activ ity uld be the combined result of their interaction with specific 
receptor proteins and wi th their urroundi ng l ipid molecules ( Reiner e[  aI, 20 1 3b). In  
a recent tud) n the nati e G BAA receptor using primary cultures of cortical 
neuron , Reiner et a1 . ,  (20 1 3  b) investigated the effects of these compounds on the 
micro visco ity of membranes by means of fluorescence anisotropy. Phenol ic 
monoterpenes such as carvacrol ,  chlorothymol . and eugenol were able to enhance the 
binding of eH ] fl unitrazepam with EC50 values in the /-lM range and to increase the 
GABA-evoked cr influx i n  a concentration-dependent manner, both effects being 
inhibited b the competitive GABAA antagonist bicucul l ine, strongly suggesting that 
the compounds studied are positive al losteric modulators of this receptor ( Reiner et 
aI, 20 1 3a) .  Col lectively, these resul ts i ndicate that thymol and other monoterpenes 
can modulate the function of GABAA receptors by direct ly  act ing on the receptors 
and also altering the biophysical characteristics of l ipid membranes. Importantly, 
some studies suggest that thymol also acts on G-protein  coupled receptors such as 
GABAB (Parker et aI, 20 1 4) and a I ,  a2, and p-adrenergic  receptors (Beer et aI, 
2007). (+)-Borneol ,  a bicycl i c  monoterpene used for analgesia and anaesthesia in  
tradi t ional Chinese and Japanese medic ine,  was also tested alone and with GABA at 
recombinant human a l P2Y2L GABAA receptors expressed in Xenopus laevis oocytes 
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u ing  the tv o-electrode voltage-c lamp technique.  (+)-Borneol ( E  :0 248 /-lM )  and ( -
)-borneol ( E  , 0  237  /-lM)  ere able to great ly enhance the effect of low 
concentrat ion of GAB . t high cone ntrations (> 1 . 5 mM)  both enantiomer 
directl acti at d G B ,\ receptors indi ating weak partial agonist act ivity (Granger 
et at, 2005) .  
The effects of monoterpene on the g l  C 1 l1e receptors are less wel l  
under to  d .  Menthol \'v as examined for i t  effect on homomeric a l  gl c ine receptors 
expr d in Xenopus oocytes (Hal l  el at, 2004) .  The results of this study revealed 
that both (+) and ( - )  enantiomers of menthol could enhance glycine ( EC20 = 50/-lM)­
induced currents (Hal l  et 01, 2004) .  
1 .... . 6 Seroton in  type-3 receptors 
erotonin type-3 ( 5 -HT3)  receptors are another member of the l igand-gated 
ion channels that belong to the Cys- Ioop superfami ly .  The effects of menthol on 
the e receptors have been described in several studies (Ashoor et 01, 20 1 3b; Heimes 
ef af, 20 1 1 ;  Walstab e f  aI, 20 1 4) .  Heimes et a I . ,  (20 1 1 )  tested the effect of menthol 
on 5 -HT3 receptors using three d ifferent in vitro models :  [ ' 4C ]guanidini um influx 
i nto 1 E- 1 1 5  ce l l s  which express 5 - HT 3 receptors, i sotonic contractions of the 
isolated rat i leum and equ i l ibrium competition binding studies using a radioactively 
label led 5 -HT3 receptor antagonist (eH ]GR65630) .  Menthol inhibited 
[ 14C]guanidinium influx through 5 -HT3 receptor channel s  as wel l  as contractions of 
the i leum induced by 5-HT. Menthol ,  however, was not able to di splace eH]  
GR65630 from 5-H T3 b inding sites. I n  tlll s study, i t  was concluded that menthol 
exerts its wel l-known antiemetic effects at least partly by acting on the 5 -HT3 
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receptor ion-channel complex b binding to a modulatory ite distinct from the 5-HT 
binding s i te .  In  another tudy. shoor et a1., (20 1 3 ) investigated the effects of 
menthol n the funct ion of human 5 - 1  IT3 receptor expressed in Xenopu lael'i 
OC) te . 5 -HT-evoked currents were re ersibl inh ibited by menthol III a 
concentration-dependent ( ICso = 1 63 11M)  manner (Ashoor el ai, 20 1 3b). The effects 
of menthol developed gradual ly, reaching a steady-state level within 1 0- 1 5  minutes 
and did not invoh e G-proteins, si nee GTPy activi ty remained unaltered and the 
effect of menthol wa not sensit ive to pertussi s tox in pretreatment . The act ions of 
menthol \vere not ster oselecti e as ( - ), (+) ,  and racemic menthol inhibi ted 5 -HT3 
receptor-mediated currents to the same extent. The maximum inhibit ion observed for 
menthol was not reversed by increasing concentrations of 5 -HT. Furthermore, 
spec i fic  binding of the 5 -HT3 antagonist eH ]GR65630 was not altered in the 
presenc of menthol. indicating that menthol acts as a non-competitive antagonist of 
the 5-HT3 receptor. F ina l ly ,  5 -HT3 receptor-mediated currents i n  acute ly  d issociated 
nodo e gangl ion neurons were also inhibited by menthol (Ashoor et aI, 20 1 3b) .  The 
results of this study demonstrated that menthol ,  at pharmacologica l ly re levant 
concentrations, is an a l losteric inhibi tor of 5 -HT3 receptors. In another study the 
impact of menthol on human recombinant homomeric 5 -HT3A- and heteromeric 5 -
HT3AB receptors i n  H EK293 cel l s  was determined by radiol igand binding, a 
l uminescence-based ci+ assay, and a membrane potential assay ( Walstab et al 
20 1 4) .  Menthol enantiomers i nhibited 5 -HT3A and 5 -HT3AB receptor with I Cso of 1 79 
and 204 1 11M for ( - )  menthol and 369 and 8 1 9  11M for (+) menthol suggesti ng 
enantiomer selectivity (Walstab et aI, 20 1 4) .  These studies i ndicate c learly that 
monoterpene menthol is an a l losteric inhibitor of 5-HT3 receptors. I n  another study, 
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car acrol and th) m J howed al losteric agonist acti i ty on human homomeric 5 -HT3 
receptor expres ed in Xenopli oocytes and also lower concentrations of these 
monoterpenes potentiated submaximal concentrations of 5-HT. I nterest ingly, both 
effect were 'pecies- peci fi as they were completely absent \ hen using mouse 5 -
H TJ recept r s  ( Lansde l l  e l  aI, 20 1 5 ) .  The  ffects of other monoterpenes on  the 
functional propertie of 5 -HTJ receptors are currently unknown and require further 
investigat ion. 
1 .5. M onoterpene and the C hol inergic System 
1 .5. 1 .  Chol inergic y tern 
cetyJchol ine (ACh) i s  the principa l  neurotransmitter in the parasympathet ic 
autonomic nervous s stem as wel l as ins ide the central nervous system (CNS) .  The 
neurochemical events in the l i fe cyc le of ACh are shown in F igure l A. Synthesis of 
ACh is dependent on the avai l abi l i ty of cho l ine. There is very l it t le de novo cho l ine 
synthesi s  i n  chol inergic neurons� therefore, the pool of chol ine i s  bui l t  mainly from 
dietary sources. Chol ine is loaded inside the chol inergic neurons from the 
extracel lu lar space by two transport systems ( Westfa l l ,  2009) .  One of them is a 
\ idely d istributed, low-affinity, sodium independent transporter whi le the other 
transporter is a h igh-affinity, sodium and chloride dependent chol ine transporter 
system. The latter exists predominant ly  i n  chol i nergic neurons and provides chol ine 
for ACh synthesis ( Westfa l l  2009) .  ACh i s  synthesized in the cytosol from chol i ne 
and acetylCoA (AcCoA) by the chol ine acetyltransferase (ChAT) enzyme and then 
loaded i nto storage vesic les by the vesicu lar acety lchol i ne transp0l1er (V AT) which 
can be inhibited by vesamicol .  When depolarized by an action potentia l ,  voltage-
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gated a2 channels  are opened and the pre naptic neuron relea es the tored ACh 
into th s) naptic left where it interact \\- ith muscarinic (mAChRs) or nicotinic 
acetylcholine receptor ( nAChRs) .  Once Ch di sociate from the receptor , it is 
rapidl} hydrol 'zed b acet lycholine tera e (A hE),  which breaks dovm ACh into 
acetate and chol ine. hol ine is then taken back into the presynapt ic neuron b 
odium-dependent chol ine transporter ( HT)  to be recycled. CHT can be inhibited 
b) hemichol inium drugs. Mo t chol inergic synapses are highly suppl ied with 
acet) lchol ine terase therefore, the hal f- l i fe of acetylcho l ine molecules in  the 
synapse i extreme I short (a  fraction of a second) ( Katzung, 20 1 2) .  Reuptake and 
avai lab i l it} of chol ine i the rate- l imit ing step in  ACh synthesis .  
AP. ... en --------�.-
Fig u re 1--':  Schematic i l lustration of a chol inergic j unction. Sodium-dependent choline 
transporter (CH T), acet) I-CoA (AcCoA). choline acety ltransferase (CM T). Vesicu lar acetylchol ine 
transporter (V AT), Peptides (P),  adeno ine triphosphate (A TP), SNA Ps, synaptosome-associated 
proteins: VAM Ps, esicle-associated membrane proteins.  (From: Chapter 6. I ntroduction to 
Autonomic Pharmacology , Basic & C l inical Phannacology, 1 2e, 20 1 2 )  
I nside the C S .  there are specia l ized chol inergic neurons. Early attempts to 
local ize these neurons were based on immunohistochemical methods to local ize 
(AChE)  enzyme. but this was not specific for special i zed chol i nergic neurons as i t  
revealed chol i noceptive neurons as wel l .  In  more recent studies. local ization of 
ChA T-immunoreactive cel l  bodies was considered as more selective and spec ific for 
chol inergic neurons (Cuel lo,  2009) .  The main central chol inergic cel l  groups and 
pathwa s are shown in F igure 1 . 5 .  In the human CNS, the cholinergic system 
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im oh e a highl) compl x network that ha three main component , the fir t h\'o 
comp nent are di ffu e. divergent projection y tern that innervate wide areas of the 
brain.  The) include : ( 1 ) projection [rom nuclei of the basal forebrain; the e include 
the m dial septal nucleu , the nu [eus basal i  of Meynert a site as ociated with 
pro� und degenerat ion in lzheimer' disease) ,  the vertical nucleus of the diagonal 
band and the horizontal l imb of the diagonal band nucleus, which innervate the 
h ippocampus. most cortical regions and ome subcortical nuc le i .  Al though this 
) tem i located in  eparate areas of the brain, the are usual ly  referred to as the 
magnocel l ular ba al forebrain cholinergic system (Me ulam el aI, 1 983 ) . (2 )  The 
pedw1culopontine-Iateral dorsal tegmental projections from the brainstem to the 
thalamus. midbrain and other brainstem regions. The third central chol inergic 
component includes (3)  in terneurons in  the neostriatum (most abundant)  and 
correspond to the caudate nucleus-putamen complex. Al 0 the ventral striatum has 
chol inergic interneuron in the nuc leus accumbens and is lands of Cal leja  ( Everitt & 
Robbins. 1 997: PelT) el al. 1 999). 
Based on the complex nature of chol inergic neurotransmission in the human 
C S. chol inergic neurons have been shown to play roles in  diverse brain functions 
such as s leep, cognition, memory, motor controL and sensory processing ( Scarr et al. 
20 l 3 ) .  For several decades, the C S chol inergic system was suspected to play an 
important role in memory and l earning. 
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Figu re 1 .5 :  A schemat ic representat ion of the human central chol inergic system -striatal 
intemeurons not sho� n. Adapted from (Fe l ten. D.L. .  and Shetty. A . .  (20 1 0). elter 's A tlas of 
Xeuro cience. :2nd Edition. Phi ladelphia :  Saunders; E l sevier. 438) .  
One of the most important early studies demonstrating central chol inergic 
function was carried out by Drachman and col laborators in healthy young human 
ubjects. The showed that subjects who were treated with low dose scopolamine. a 
muscarinic antagonist. showed s imi lar memory and cognitive dec l ine aged subjects 
( Drachman er aI, 1 980) .  There is experimental evidence ind icating that the basal 
forebrain chol inergic neurons do participate in attention, learning, and memory 
functions ( Gibbs & Johnson. 2007; Leanza et aI, 1 996; Wrenn & Wiley, 1 998) .  
Several earl ier invest igations have highl ighted the role  of the cho l inergic system in 
condit ioning and sensory learning ( Deiana el aI, 20 1 1 ;  Robinson ef al. 20 1 1 ) . The 
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general ob  ervat ion i that bl ckade of both mu carin ic and nicotinic receptors led to 
\\ ide pread impairment 1 11 either acqui i l ion learning or long-term memory 
proce mg. and thi can be rever ed b boo t ing 1 vels of Ch.  Consi stently. 
t imulation of ei ther mu carinic ( main ly  M 1 )  or nicotinic (predominant ly  a7)  
receptors \Va beneficial for learning and memory and ha been suggested to be 
\aluable in the treatment of neurodegenerat ive or psychiatric d isorders with 
cognit i \'e impairn1ent ( Deiana ef al. 20 1 L Robin on el ai, 20 1 1 ) . Researchers have 
hO\\11 that yariable performance of the central cholinergic system in the e lderly ,  
mea ured b y  a e i ng  the ChE enzyme acti i t)'. is  c losely l i nked and can underl ie 
the i nter-individual variabi l i ty in  memory function ( Richter et al. 20 I 4) .  Therefore. 
chol inergic dy function can be con idered an earl hal lmark even before onset of 
dementia. 
The nicot in ic a7 receptor subtype was found to be involved in working 
memory. wherea the a4�2 subtype has been l i nked to tests of attention. In addition 
to leaming and memory. n icotinic receptors are also assoc iated with the modulation 
of depression and arLxiety ( Graef ef ai,  20 1 1 ) . 
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1 .5.2.  icot in ic receptor 
icotinic acetylcholine receptor ( nAChRs) belong to a large fami ly  of 
l igand-gated ion channels  that include also G BAA receptor , serotonin 5-HT3 
receptor and glycine receptor . everal tructural features are conserved in  a l l  
members of thi gene family.  most notably a di  ul fide- l inked equence of fifteen 
amino a id that con ti tute what is cal led the " ignature Cys- Ioop" and the whole 
fami l ;  i referred to as the "Cy -loop uperfami ly" of l igand-gated ion channels 
( Gotti el 01. _009) .  The nicotinic receptor was the first pharmacologic receptor to be 
purifi d and the cD As encoding its subunits c loned . therefore they are considered 
a prototype for the l igand-gated ion chatmel fami ly ( l t ier & Bertrand. 200 1 ) . 
icot inic receptors are widel. distributed in  the central  and peripheral ner ous 
; tem . I n  keletal musc le they are found in  a high den ity a t  the motor end plate. I n  
gangl ia. the primary nicotinic receptor is found on  the postsynapt ic dendri te and 
ner\'e cel l body. In the C S. the majority of receptors are presynapt ic .  so they have 
regulatory function as they control the release of other transmitters or work as 
autoreceptors i n  chol inergic neurons (Gotti et al. 2006; Taylor. 20 1 2 ) .  
Overal l ,  n icotinic receptors are ionotropic receptors that exist as  pentamers 
with i ntrinsic cation-permeable pores that are gated by the binding of ACh. The five 
subunits of the receptors can be identical (homomeric )  or variable (heteromeric ) .  
Muscle-type ACh receptors were first i solated from electrical organs of fishes such 
as Torpedo marmorala ( Karl i n, 2002 ; Unwin. 1 998) .  The receptors in  Torpedo 
electric t issue and i n  fetal muscle are heteropentamers, with subunit composition of 
a2�Yo (Figure 1 .6 ) .  In adul t  muscle, the receptor contains an £ subunit in p lace of the 
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Y ubunit and ha a greater ingle-channel conductance and a mai ler mean ingle­
channel -open time than fetal receptor ( Hurst el al. 20 1 3 ) .  There are nine other 
neuronal a ubunits ( a2---a l O ) and three known neuronal p ubuni ts W2-�4);  the a 
ubunit const i tute the principal  compon nt for binding site, whi le the p subunit is a 
complementar) component of the receptor ( H urst el ai, 20 1 3 ) .  orne neuronal a 
ubunit (e .g . ,  a7)  form functional homopentamers. Different regions of the 
peripheral and central nervou system e 'press di fferent combinations of the neuronal 
ubunit ( Karl in. 20 1 0 ) .  
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Figure 1 .6 :  Structure o f  n i co tinic ACh receptors. a I The structure of each subunit of 
nAChR con i sts of p- trands. four transmembrane a-hel ices segments ( M  l -M4), a variable 
intracel lu lar loop between M3 and M4, and an extrace l lu lar carboxy-tenn inus. The extrace l l ular 
domain carrie the ace!) Icho l ine-nicotine binding sites at the boundary between subunits. The 
number of binding sites per pentamer is variable. depending on its composition, from two ( in muscle 
nAChRs or brain a4p:2 nAChRs) to fi e (in the a7 homopentamer). ites for a l losteric modulators are 
located in the transmembrane domain.  b I A schematic representation of the quaternary structure, 
showi ng the arrangement of the subun its in the m uscle-type receptor, the location of the two 
ace!) !chol ine-binding sites (betvveen an alpha- and a gamma-subunit. and an alpha- and a delta­
subunit). and the central cation-conducting channel. c I A cross-section through the 4 .6-A structure of 
the receptor deteml ined by e lectron microscopy of tubular crystals of Torpedo membrane embedded 
in ice. Dashed l ine indicates proposed path to binding site (Adapted from Karl in ,  2002) .  
1 .5.3. Neuronal  n icoti n ic receptors 
The most abundant subtypes of nicot inic receptors in the brain are the low 
afflnity a7 homomeric and high affinity a4p2* heteromeric nAChRs (F igure 1 . 7) .  
Different subunit types are distributed i n  most central chol inergic areas as shown in 
table ( l ) . Due to variable types of subunits, heteromeric nAChRs are rather complex 
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a the) can contain two or three alpha ubunit co-as embled with two or three beta 
ubunits. F r e. ample, a4�2 nAChRs can be formed either as [ (a4hW2h] or a 
[ (a4 )3W2)2 ] .  Thi variabi l i t  cau e many d ifference between the various fonTIs of 
n C hR . In the previous e. ample, [ (a4hW2 )3 ] nAChRs showed very high 
en iti\ ity to Ch that i almost 1 00 t imes greater than that of [ (a4 )3 (�2)2 ] nAChRs 
( Moroni el a1, 2006: Zwart & Vijverberg, 1 998) .  I n  addition, some subtypes 
ident i fied expre more than one type of alpha and/or beta subwlit .  For exanlple, the 
a4a6���3* nAChR was detected in midbrain dopaminergic neurons ( L iu ef aI, 
2 0 1 2) .  
A Homomeric nAChRs B Heteromeric nAChRs 
0 7  09 04132 0406132133 
Figu re 1.7 :  Schema t ic prese ntat ion of  homome ric a n d  heteromeric n A C h Rs .  
( A )  Homomeric receptors consist of ubun its on ly  and usual ly have 10\ affinity for agon ist .  
To date. only mammal ian 07,  09, and 0 I 0 ( not shown) subunits may form functional homomers. ( 8) 
The majority of h igh affinity nAChRs are heteromeric and consist of a combination of 0 and P 
subun its. Important l  • .  m ultiple 0 subunits may coassemble with mu lt iple  P subunits in the pentameric 
nAChR complex ( i l l ustrated here by 0406P2P3 ) .  ACh binding sites are depicted as red triangles 
( Adapted from Hendrickson el ai, 20 1 3 ) .  
The most abundant homomeric a7 nAChRs has been extensively studied 
owing to its unique physiological and pharmacological properties. It is  exc lusively 
characterized by high permeabi l ity to Ca2+ ( PCa:PNa of � 1 0  compared to 3-4 for 
most other nAChRs) and rapid desensi t ization. The a7 subunit  is expressed at high 
leve ls  in the h ippocampus and hypothalamus ( Seguela el aI, 1 993 ). S ignificant 
proportion of a7 nAChRs are located on presynaptic terminals where they faci l i tate 
�o 
�+ dependent re lea e of neurotran mitter . Th is may ccur indirectly as a result of 
a inOux cau ing membrane depolarization and activation of vol tage-gated 
a.2 hann I or directl b a2+ i n flux through the nA hR itse l f  (Albuquerque, 
2009). Eventual increa e of intracel l u lar Ca2+ level upon nAChR activation makes 
these re eptor rele ant for the regulation of other Ca2+ -mediated events such as cel l  
excitabi l i ty ,  act ivation f second me senger pathways, gene expression and cel l 
d i fferentiation ( Berg & Conroy, 2002 ). The change in the pattern of a7 nAChR 
expr ion over time suggest that these receptors pia a role during brain 
development. Their concentration I S  high during the stage of synapse fom1at ion 
Gotti & Clementi ,  2004) .  During development, a7 nAChRs are also expressed in 
non-neur nal cel l types, including musc le, gl ia, epithel ia l  cel ls ,  and 
chondrocytes ( Berg & Conroy, 2002; Gotti & Clement i ,  2004) .  
Cortex 
Frontal  
Tem po ral  
Parietal 
M i d b ra i n  
H i ppoca m p us 
E ntorhinal  Cx 
P ra m idal cells 
Dentate gyrus 
Basal ganglia 
Putamen 
Caudate 
Cerebell u m  
«4 as «6 «7 
Table 1 :  N icot in ic  receptor subunit protein expression in  human brain (Adapted from Gotti  & 
C lementi,  2004) 
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1 .504.  ico t in ic  receptor and  monoterpone 
t\ mention d earl i r, being one of the most widely di tributed nicot inic 
r ceptor subtypes in d i fferent higher brain areas, a7 nAChRs have been proven to be 
i m  Ived in man) neural ph siological and pathological condi t ions. There i 
considerable intere t in find ing selective l igand for nAChRs indi idual SUbtypes. I n  
ea  e of homomeric a7 n ChR , many reports have ind icated the beneficial  effects of 
a t ivation of these receptor in impro ment of cognit ive deficits of patients with 
schizophrenia and lzheimer's disea e (Bourin e{ aZ, 2003 ; D'Andrea & Nagele, 
2006; Deut ch ef a1, 20 ]  4;  Lei er et ai, 2009; Levin,  2002; Ripol l  el aI, 2004; 
Thom en ef aI, 20 ] 0: Wal lace & Porter, 20 1 1 ;  Young & Geyer, 20 1 3 ) . 
Fewer studies, most ly i n  mice and rats, have demonstrated that a7 nAChRs 
antagonism showed anti-depressant act iv i ty using several common tests of 
antidepre sant efficacy i nc lud ing the forced swimming test and tai l  suspension test 
(Andreasen et aI, 2009; Rabenstein et aZ, 2006). C l in ical  data elucidated that the non­
selective nAChR antagonist, mecamylamine, reduces depression- l i ke symptoms 
suggest ing that target ing nACh Rs could be a reasonable strategy for developing 
novel antidepressant medications ( Shyt le  et aI, 2000; Shyt Ie et aI, 2002) .  
I nterestingly, the a7 nAChRs have also been suggested to  p lay an  important role in  
both central and peripheral mechanisms i nvolved in  eat ing behavior and energy 
balance (reviewed in detai l s  by McFadden et aZ, 2 0 1 4) .  
I n  the context of searching for selective novel agents that modulate the 
act ivity of nACh Rs, natural phytochem icals have proven to be a good source at least 
for structural model s  ( Daly, 2005 ; Romanel l i  et aZ, 2007). Regarding monoterpenes, 
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only few tudie ha\ e been performed to creen the effects of the monoterpenes on 
nicot in ic receptor . Park and co-workers te ted the of effect of camphor ( Park el at, 
200 I )  and b me 1 ( Park el ai, 2003 ) on catecholamine secretion in bovine adrenal 
chromaffin cel ls. Botb compounds reduced eH ]norepinephrine secret ion induced by 
a n ChR agonist ,  L I -d imethyl -4-phen Ipiperazin ium iodide ( DMPP)  with s imi lar 
I Cso value ( 70 )lM) .  To confi rm that this effect i s  mediated by nAChRs, cyto ol ic 
Ca2+ and a + level were measured upon treatment of the cel l with DMPP alone and 
in the pre ence of monoterpenes. The ri e of [Ca2+ ] [  and [Na + ] " an essential step for 
the relea e of catecho lamine by nAChRs acti ation, was inhibi ted with an ICso of 
88 and 1 9  )lM for camphor and 56 and 49 )l M for borneol ,  respectively .  B inding 
a say of eH ]nicot ine to nAChRs showed that these monoterpenes did not alter the 
binding of nicotine i ndicating that the ir  binding site is d ist inct  from nicot ine's and 
ACh binding sites. However, another monoterpene, carvacrol was examined on 
nAChRs of housefly and howed non-competi t ive concentration dependent 
inhibition of e4C] -nicotine binding (Tong el ai, 20 1 3 ) .  
I n  earl ier studies, i t  was shown that menthol i s  an  antagonist of nAChRs as 
wel l .  Hans and co-workers studied the effect of (-)-menthol on nicot ine i nduced 
current t hrough nAChRs recorded in rat trigeminal neurons (Hans et ai, 20 1 2) .  
Menthol showed reversible and concentrat ion-dependent i nhibi tion of nAChRs. 
S i ngle channel  and whole-cel l  recordings from recombinant hwnan a4p2 nAChR 
expressed in HEK tsA20 1 cel l s  demonstrated that ( -)-menthol is a negative a l losteric 
modulator of th is nicotinic subtype ( Hans et ai, 20 1 2 ) .  The effect of menthol was 
also examined on another subtype, a7 nAChRs, expressed in Xenopus oocytes by 
recording ACh-induced currents us ing the two electrode voltage c lamp technique. 
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Racemic.  ( - )  and (+) fonns of menthol caused concentration-dependent, non­
compet i t ive inh ibi t ion of a7 nAChR . Consistent with these results, experiments 
donc on neural cel l ( PC 1 2) endogenously expressing a7 nACh receptors 
demon trated that menthol attenuates a7 mediated Ca2+ transients in the cel l body 
and neurite ( hoor et af. 20 1 3a).  
Drug dcvelopment efforts have recently focused on direct manipulation of a7 
and a4�2 nAChRs. fonoterpenes could be helpful  in better understanding of factors 
in flu  ncing the e nicot in ic ubtype and their function and may provide spec ific drug 
candidate or at least lead structures for further design of monoterpene-based 
compound . 
Chapter 2 :  Aims and O bj ectives 
ur main obje t iv \\ as to investigate the effect of car col and other related 
1110n terpenoid on the functional propert ie of a7 nACh receptors. 10 al l  
experiments, hOll1omeri human a7 nACh receptors were expres ed heterologously 
in a Xenopu ' oocyte expre ion )' tem .  This e. pression sy tem is  conveni nt for 
a sa ' ing the action of te ted compounds on cloned receptors for the fol lowing 
r a on . 1 )  Procedure for acquir ing and maintain ing oocytes are wel l  establ ished. 
Therefore, large number of effic iently expressing oocytes can be easi ly  obtained on a 
rout ine ba i s  for the intended experim ots. 2 )  T\ o-electrode voltage c lamp al lows a 
relat ively  high throughput a ay 0 se eral ce l ls  can be screened on a dai l y  basis .  3 )  
Recording u ing t�o-electrode voltage c lamp can be stable over long periods of  
t ime, which makes i t  part icularly u eful  for analyzing properties that requ ire long 
protocols, su h a slow t ime course of drug action. 
I n  the present study, se eral  monoterpenes were screened to test thei r  effects 
on the act ivity of hwnan a7 nACh receptor expressed in Xenopus oocytes. In order 
of fu l ftl this goal, the fol lowing experiments were done: 
1 .  Functional expression of human a7 nACh receptor i n  Xenopus oocytes. 
2 .  Exploring the effects o f  the selected monoterpenes o n  the function o f  human a7 
nACh receptor. 
3 .  Defining voltage-dependence o f  cavoel 's  action on the a 7  nACh receptor. 
4 .  I nvestigating the involvement of cytoso l ic  calc ium in  the effects of carveol on a7 
nACh receptor. 
5 .  Detenni nation o f  the binding s i te o f  carveol in  the a7 -nACh receptor. 
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Chapter 3: M a teria ls  and Methods 
3. 1 An imal  and materi a l  
3. 1 . 1  An imal : Female Xellopu laevis 
Matme II male [ri can c lawed frog (Xenopus faev; ) \ ere purchas d from 
Xenopu Expre . Haute-Loire, France (F igure3 . 1 ) . They were kept in  a container 
( '2  cm width. l 30 cm length and 66 cm height ) fi l led to a height approximately  50 
cm with chlorine-free water. The room temperature was maintained at 1 9-2 1 °C with 
a 1 2  hour alternate l ight and dark cycle. Frogs were fed twice a week with food 
pel let . uppl ied by Xenopus Express, France. Tank-water was changed twice a 
week. Animal care and handl ing were con istent with institutional guidel ines. 
Figu re 3. 1 :  An adult  female Xenopus laevis. 
3. 1 .2 hemical  
BA PTA 
Barium chloride ( BaCh) 
Benzoca ine  
Calc ium chloride (CaCh) 
Collagen a e-A ( From 
Clostrid ium h i  tolyt icum 
EC.3.4.2.t.3) 
G entamic in  reagent  o lut ion 
H EPE 
Hydrogen chloride ( HCI)  
-;\Iagne i u m  ch loride 
M agne ium ulphate 
Penic i l l in  G 
Pota i u m  ch loride (KCI )  
Sod i u m  b icarbonate 
( -aHC03) 
Sod i u m  ch loride (NaCl)  
odium hyd rox ide (NaOH) 
odi u m  p�' ruvate 
Streptomycin 
0.- B u nga rotoxins  
Fo rmula weight 
I 1 . 7 
764.68 
244 .28  
1 65 .2  
1 1 0.9  
Cone . 50mg/ml 
238 .3  
3 7% 
95.22 
246.5 
3 56.4 
74.55  
84.0 1  
58 .4  
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1 1 0 .04 
1 457 .4 
-8500 
igma-Aldriehl A- I 076 
BDH. England/R-20-25 :45 
Sigma. U E- 1 50 1  
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igma-Aldrieh. U A / C-490 1 
Roehe Diagnostic Corporat ions 
U AI Lot number 932 1 1 52 1  
I nv itrogen Corporation/Ch ina Cat . 
munber 1 5750-060 
igma, USA I H 3 3 75 
igma-Aldrieh. USA 125 . 8 1 4 .B  
S igma, SA I M8266 
S igma. U SA I M9397 
igma. USA / P3032 
Mal l inckrodt USA I 6858 
igma. U SA I 60 1 4  
S igma, U SA / S-30 1 4  
Arnresco. SA I 
Lot. # 2 1 46 1 30 1 0  
Sigma-A ldrich, USA 1P2256 
igma, U A I 9 1 37 
S igma I T -0 1 95 
Table 2 :  Chemicals required for experiments. 
3. 1 .3 Experimental  setu p 
The experi mental setup for electrophysiological recordings usmg two 
electrode oltage c lamp i s  shown in F igure 3 . 2  and 3 . 3 .  Two-electrode voltage c lamp 
(TEVC) technique was appl ied using a GeneClamp-500B amp l ifier (Axon 
I nstruments. Molecular Devices, Inc . ,  Sunnyvale CA. USA), as described previously 
( Ashoor el af. 20 1 3a)  recordi ng setup i nc luded magnetic holding devices ( Kanetec 
U A Corporation. Bensenvi l le, I L, USA),  two manual micromanipulators (M33 ;  
i\ 1 iirzhauser. 
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tzlar. GenTIan ) and head-stage for voltage (H  -2 Headstage. 
Gain I G. Axon I nstruments. Molecular De ices. Inc . .  unnyvale. C A )  and 
current (H -2 Head tag , Gain 1 0MG) attached to manipulator . Electrodes were 
in  ert d in  electrode hold r and connected to the head- tages. 
The perfu ion apparatu con isted of perfu ion tubes and bott les containing 
e. tracel lular olution connected to the recording bath by s i l icon tubing (Cole 
Parmer I n  trument Compan , I . D. 1 1 1 6  i nch, O.D. 1 /8 inch and WAL L l /32, Vernon 
H i l l , l l l i noi , A) .  F low rate of perfusion was set to 3 to 5 m llmi nute. A 
mult ichannel perfu ion sy tern was used for drug appl ications inc luded tubing (C­
F lex tubing. Cole-Parmer I nstrument Company, I . D. 1 /32  inch, O .D. 3/32 inch and 
WALL 1 I3 2  i nch. Vernon H i l ls. I l l i nois. USA).  50 m L  glass syringes, plastic  valves 
and coupl ing device . The drug appl icat ion ystem was based on gravity flow by 
mean of a micropipette that was set at a d istance of about 2-3 mm from the oocyte 
po i t ion i n  the perfusion chamber/recording chamber ( Warner I nstruments LLC, 
Hamden, CT. U K) designed for plac ing oocyte to be impaled with the 
m icroelectrodes (F igure 3 . 3 ) .  I n  in i t ia l  contro l  studies using high K + ( 20 mM) 
conta ini ng sol ution. we detennined that the response t ime of our recording system is  
0 . 1 to  0.4 sec (0 .32 ± 0.07 s: mean ± SEM, n=8) .  
An optic  fiber l ight source was used for i l l um ination of the recording 
chamber (F iber L ite, H igh I ntensity I l l um inator Series 1 80, Dolan-Jelmer I ndustries 
I nc .  Boxborough, MA, U A). A Low-power stereo-dissection m icroscope 
(Olympus, Tokyo, Japan, SZ-STB l ,  1 00 ALO.S X, W D 1 86) was used for visual 
observation of the recording chamber. The computer set up for recording consisted 
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of a ompaq computer, ( ompaq Corporation. Product of UK.  i ty of Wynyard ) 
and analog-digital c n erter. B C 208 1 ational T n  trument , Au t in Texa , U  A ). 
Fig u re 3.2 :  A photograph of the two-e lectrode oltage clamp used to study the alpha? nicotinic 
receptor in  Xenopus oocyte. ACh sol ution (4,7) and perfusion solution (3) l ines are connected by 
tubes to the chamber (9). M icromanipulators (6) are used to control e lectrodes (8) to impale the 
oocyte \ i sual ized using m icroscope (5). An ampl ifier (2) is  used to record current traces ( I ); 
Acquired data were stored on a computer ( Prof. Murat Oz Lab). 
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SuctlOJl \yaCmun) Oocyte ]ocaUOJl 
Recording Cbamber 
Fio u re 3.3: l l l u  (ration of the plastic chamber.The oocyte was placed on the chamber and perfused 
continuous I) during the experiment. The suction l ine conveyed the solution to a waste flask. 
3. 1 --'  Other material 
Material 
utomatic nanol i ter i njector 
Boros i l icate Gla  tubing for 
microelectrodes. 
Electrode holder 
.:\lagnetic tand and manipu lators. 
M icro-� M icrosyringe pump contro ller 
l\l icrofil fil l ing yri nge 
Petri d ishe 
p H  meter 
Specifications/company 
Nanoject, Drum ond Scient ific 
Company, Broomall .  P A. USA 
Glass Thin-wal led w/fi lament 1 . 5 nm1, 
Cata logue number: TW 1 50F-4. World 
Prec ision Instrument. arasota. Fe USA 
World Prec ision I nstrument. Sarasota. 
FL .  USA 
Cata logue number: 7739. N arish ige . 
Tokyo. Japan 
Model UMC4-C, World Prec ision 
I nstruments. Sarasota, FL USA 
World Prec ision I nstruments, Sarasota. 
F L USA 
Steri l in. Newport. UK. Catalog number: 
1 27, 60 mrn 
Corn ing pH meter model 450, A lbany. 
Y, USA 
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Picofuge 
R. a. e free ,\ ater in 1 .8 mL Eppendorf Lot number: M25-80502. Epicentre 
tube Biote hnologie . Madi on. Wisconsin, 
Si lver w i re 
t i rrer 
S u rgical acce orie 
u rgica J u t u re 
Vertica l  pu l ler ( H eater and  solenoid 
setting lHre adj usted to -&8 and 70, 
respectively, to get opt imal  re i tance 
( 1 -2 ;\fQ) glas m icroelectrodes) 
World Preci ion Instruments, ara ota. 
FL 
Rotomix. Type 50800. 
Bam tead/Them10lyne, Dubuque, lA -
U . Model number: M50825 
Sci sor . forceps, calpels:  World 
Prec ision I nstrument. Sarasota. F L. USA 
Catgut chromo  reyerse cutting 3/8 c ircle,  
U P 4/0, SML DemeTech corporation, 
1 i ami .  F lorida, U A 
Model 700D. David Kopf lnstruments. 
Tuj unga. CA, USA 
Table 3: Required materia ls  
3.2 olut ion  req u i red 
3.2 . 1  Preparation of M od ified Ba rt h '  o lut ion ( M B  ) 
The c mpo i t ion of Modified Ba11h olution is hown in the table below. 
a. a lc ium-free Modi fied Bath o lution. 
5 1  
C o ncen trat ion(m M) I x  (weigh t  in  gra m )  l Ox (weight in  gra m )  
' l gS0� 
laC!  
-a H C03 
1 0  
1 
0 .8  
88  
2 . 4  
2 .38  
0.075 
0.20 
5 . 1 4  
0.20 
Table 4 :  Calcium-free MB olution compo ition. 
23 .8  
0 .75 
2 .0 
5 1 .4 
2 .0 
The above ub tances were dissolved i n  1 L of dist i l led water and the pH of the 
resul t ing o lut ion wa adjusted to 7 .5  using aOH. 
b. 10dified Barth ' s  olution with Calcium. 
im i l ar to pre ious composit ion but in add it ion of 2 mM eaCh (0.22 g for 1 x and 
2 .2  g for l Ox stock solut ions), and the final solution is made up to 1 L  with dist i l led 
\�'ater and pH adj usted to 7.5 with aOH. 
3.2.2 Preparation of frog's Ringer so lut ion ( N D96) 
The composit ion of the ND96 bathing sol ut ion is  given in the table  below. 
Compounds  
NaCI  
H E PES 
KCI 
M gCh 
CaCh 
O R  BaCb 
Concen trat ion ( m M) 
96 
5 
2 
1 
1 .8 
1 . 8 
I x  (weigh t  i n  gram) 
5 .6 1  
1 . 1 9  
0. 1 5  
0 . 1 0  
0.20 
0.43 9 
Table 5 :  N D96 solution. 
1 0  x (weight  in  gra m )  
56. 1 
1 1 .9 
1 . 5 
1 .0 
2 .0  
4 .39 
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The abov weighed ub tance \.vere di  olved t make 1 L o lution \',;ith dist i l led 
\\ at r and the pH wa adju  ted to 7 .5  u ing aOH .  
3.2.3 Prepa ration of  oocyte torage o lu t ion 
Compo u n d  Concentrat ion ( m M )  
NaCI 88 
H EP E  1 0  
j 'a H COJ 2..+ 
KCl 1 
:\ lgSO" 0 .8  
CaCh 
Penici l l in  G 1 0000U/L 
Strepto m) c in  1 0  mg/L 
G en tam) cin  50 mg/L 
o d iu m p� ru\'ate 2 
Theophyll ine  0.5  
Weigh t in  gra m 
5 . 1 4  
2 . 38  
0.20 
0.075 
0.20 
0.22 
0 .0 1 9  
0.0 1 
2mL 
0.22 
0.09 
Table 6 :  Ooc tes storage solution. 
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3.3 M et h  d 
3.3. 1 I o lat ion of oocyte from Xenopus laevi 
XenojJu laevi ' female frog v. as ane thetized b keeping it in l L  of 0.03% 
v"/v benzocaine olut ion. prepared by di  01 ing 300 mg of ethyl p-aminobenzoate in 
1 5  mL of 70 % ethan 1 and then adding that to 1 L of cold tap water. The end point of 
ane th ia wa determ ined by fai l ure to respond to noxious t imuli l i ke p inching of 
the lo\\ er l imb . On av rage i t  took 5- 1 0  minutes to achie e ane thesia under the 
de cribed condit ion . Experimental procedures appl ied in  this study ha e been 
appro\'ed by the Animal Ethic Committee of the CMH . UAE University. 
The ane thetized frog was then placed on crushed ice covered with a wet 
t i  ue paper to  avoid  sk in  from dry ing out  during surgery and to maintain low core 
body temperature. ter i le surgical procedures were appl ied to remove oocytes. 
teri l ized surgical tool and regular use of 70 % ethanol was employed to maintain 
oyeral ! steri l i ty . A mal l  i nc ision was made through the epidermal layer i n  the lower 
abdominal area of about 1 . 5 cm length sl ight ly to the left or right of the mid l ine. and 
a s imi lar cut i n  the i nner muscular layer. Using steri l ized forceps. one to two ovarian 
lobes ( mal l  c lumps of oocytes) were removed and placed in a petri d ish conta in ing 
Ca2-_ free MBS ( Figure 3 .4) .  After removing the ovarian lobes, the muscular layer as 
wel l  as the outer skin was sutured with absorbable Catgut sutures. After surgery. the 
frog was kept in a contai ner fi l led with tap water and c lose ly monitored for recovery. 
After 3 -4 hours of recovery, the frog was returned to the main frog container. Each 
frog was uti l ized for three to four surgeries keeping a gap of two to three months 
between each procedure. 
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Figu re 304:  A :  An 0 arian lobe. contain ing ooc)'tes a t  d ifferent de  e lopmental stages. B:  Separating 
ooc)te b) remo\ al of epithe l ial  and fol l icular layers manua l ly with tine forceps. 
3.3.2 Oocyte p reparation 
The preparat ion of oocytes was performed according to procedures described 
earl ier (Oz. Ravindran. Diaz-Ruiz. Zhang & Morales, 2003 ). Using fine forceps, 
i nner ovarian epithel i um. theca, and fol l icular layers were removed as much as 
possible to produce smal ler c lusters of oocytes. The result ing oocyte c lusters were 
then treated for one hour with 1 2 . 5  mL of col lagenase sol ut ion, prepared by 
dissol ving �O mg of Col lagenase-A i n  25 mL of Ca2+ free M B  , in a smal l  cortical 
fl ask with continuous stirring ( 60-80 RPM ). This procedure was repeated again for 
another one hour using the remaining fresh col l agenase solution ( 1 2 .5  mL) .  
Afterwards. oocytes were washed thoroughly  wi th  Ca +2 -free MBS s ix  t imes. then 
with Ca2+ containing MBS another six t imes. Subsequently ,  oocytes were transferred 
to a petri dish contain ing MBS for selection using a dissecting m icroscope ( Bunton 
I nstruments Co I nc .. Model GSZ, Rockvi l le ,  MD.  U .S .A . ) .  
Morphological ly  intact. healthy looking and mature oocytes (stage V-V I )  are 
selected. These oocytes are large in size. round i n  shape, about 1 . 1  to 1 .2 mm in  
5 5  
diameter and have characteri t i c  brown and \ h ite colored pole , a dark brown 
animal pole and a ) e l lo\-vi h vegetal pole ( Figure) .  The oocyte were ub equentl) 
maintained in  MB at 1 8 °C. 
Figu re 3.5 :  I so lated stage V and V I  oocyte of Xenopus laevis after col l agenase treatment. 
3.3.3 Sy nthesis of cRNA 
The cD A c lone of human a7-nACh was k indly provided by Dr. 1. 
L indstorm ( n iversi ty of Pennsy lvania, PA, U .S .A . ) .  Capped cRNA transcripts were 
synthesized in vitro using a mMESSAGE mMESSAGE k i t  ( Arnbion, Aust in ,  TX, 
U .S .A . )  and analyzed on 1 .2% formaldehyde agarose gel to check the size and 
qual ity of the transcripts (F igure 3 .6) .  
Figu re 3.6: Agarose ge l analysis of m RNA. 
Lane 1 :  E B  ssR. A ladder \\ ith 9.7.53,2 . 1 .  and 0.5 k i lo  bases markers. 
Lane 2: 2 f1g RNA of 5-HT3A receptor. 
Lane 3 and 4: 1 .5 and 0 .75 f1g m R. A of 5-HT3A receptor. respectively. 
Lane 5 :  3 f.1g R A of a7nACh receptor. 
Lane 6 and 7: 1 . 8 and 0.9 f.lg mR. A of a7 nACh receptor. respectively. 
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Human a7 nACh receptor mRNA wa prepared by in vitro transcription and 
confinued by gel analysis .  Restriction enzyme ( Xbal ) was used to digest the cDNA 
of human a7 nACh receptor. L inearized plasmid cDNA was transcribed in vitro by 
P6 RNA polymera e to produce a7 nACh receptor RNA using a mMESSAGE 
mMACHINE kit .  This RNA was c leaned and purified by phenol : ch lorofom1 
extraction and ethanol precip i tation. The quantity of RNA was estimated by OD260 
measurement and qual ity was assessed by agarose gel . Capping enzyme and 2 '  -0-
methyltransferase were used to add a cap and poly( A)  tai l  to RNA. and the resul ting 
m RNA was suspended in  DEPC-treated water. Once more. mRNA was cleaned by 
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phenol :chloroform extraction and ethanol precipitation, then run against RNA m 
agaro e g 1 to confirm the addit ion of 5 "  cap and 3 '  poly(A )  tai l ( F igme 3 .7) .  
3.3"" I nj ect ion of  cRNA  into oocyte 
The oncentrat ion of human a7 nACh receptor m RN synthesized was 3 . 7  
Ilg/llL.  I t  \\. a stored in 1 ilL al iquot in -80 °C freezers. On the day of injection only 
one a l iquot \'va tran ferred to the laborator on ice. In order to control RNase 
contaminat ion. glove and face rna k \ ere u ed and the bench wa wiped with 70% 
ethanol before handl ing cRNA. E ight ilL of RNase and D ase-free water was added 
to the cRN using a teri le  p ipette and RNase free and DNase free t ips ( Denv i l l e  
c ientific I nc . .  Metuchen. J .  U .  .A . ) .  Only 3 111 of di luted cRNA was used for one 
batch of ooc)1es and the remaining c RNA was returned to the freezer. 
\ ert ical pul ler \ as u ed to pul l an autoclaved glass capi l lary ( World 
Prec is ion I nstrument . Sarasota. FL. USA) to make a needle i th a long shaft. The 
t ip  of the needle  wa broken by applyi ng pressure using fine forceps (F ine Science 
Tools  I nc.  Vancouver. BC, Canada) under the dissect ing microscope ( Bunton 
I nstrument Co. Rock i l le, MD,  U SA) .  The needle was back fi l led with m ineral o i l  
( igma. St .  Louis, MO,  USA)  using a g lass 1 mL syringe. The needle was then 
placed in the micro-dispenser connected to a m icromanipulator. Before start ing the 
m icro injection procedme, the surface of the microdi spenser and the m icroscope was 
c leaned with 70% ethanol .  To the centre of a drop of m ineral o i l  kept on parafi l m  
( American ational Can. Greenwich, CT, U SA), 3 ilL of e ither d i luted c RNA or 
dist i l led water was transferred . Using the microscope, the intended aqueous phase 
was careful ly  withdrawn into the needle using the microdi spenser control panel . 
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Thereafter. d nud d elect d oocyte are plac d in  a petri d ish containing MB and 
hm ing a m h bottom to prevent movement of oocyte during the microinjection 
pro edure. Each oOC}1e wa inj cted \ ith 25 nL of mRN by the nanol iter injector. 
dri \ en by a Micro-4. m icro- ringe pump contro l ler. Last ly,  injected oocytes were 
kept at ] 8 0 in  a petri d ish containing oocyte storage solut ion for 48 hours for 
opt imal expre ion of a7  nAChRs. The injected oocytes were used for 
electroph} io logical experiment during a period of one week.  Every day after the 
m icroinjection procedure, the storage o lution was exchanged and dead or unhealthy 
oocyte were removed. 
3.3.5 Drug p reparation 
tock solut ions of tested compounds were prepared 1 11 m i l l imolar 
concentration in  D96 olut ion using the fol lowing fom1Ula :  
Weight i n  m g  = ( M W )  x (volume i n  L )  x (mM concentration) 
Further d i lut ion were prepared by using Charles equation : 
Where. 
C 1 = concentration of stock solution 
V I = volume of stock sol ut ion to be used 
C2 = desired concentration to be prepared 
V2 = desired vol ume to be prepared 
Fresh stock sol ut ion and further d i lut ions were prepared before start ing experiments. 
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3.3.6 Tn o-elect rode voltage clamp record ino  
Two-electrode vol tage clamp ( TEVC) is  a con entional electrophysiological 
technique u ed to art i fic ia l ly control ( r c lamp)  membrane potential using feedback 
ampl i fier in large c 11 to study the propert ies of electrogenic membrane proteins 
uch a ion channel . The functional propert ies of ion channels exogenously 
. 'pre ed in Xenopus oocyte can be tud ied convenientl using this technique. I n  
TE  C.  two intracel l u lar microel ctrode are emplo ed, a ol tage sensor electrode 
and a current injection electrode to control membrane voltage. I n  this way. 
membrane potent ial can be et at a desired value and current through the membrane 
can be recorded to analyze ion channel properties. The i njected current to maintain 
onUl1and voltage is equal to total membrane current ( Figure 3 . 7) .  
Channel 
protem 
Two-el ectrode vo ltage c la m p  
V 2  or 12 
Clamping 
amp 
Membrane 
voltage 
Command 
voltage 
( i nject current) 
Current-to-voltage 
converter 
Recorded ion 
channel current 
Figu re 3.7: Schemat ic i l lustration of two-electrode voltage c lamp setup using Xenopus oocytes: The 
membrane of the oocyte is penetrated by two microelectrodes, one for voltage sensing (V I )  and one 
for current i njection ( 12) .  The membrane potent ia l  as measured by V 1 and a h igh input impedance 
ampl ifier (amp I )  is compared with a command voltage. and the d ifference is brought to zero by a high 
gain feedback ampl ifier (amp 2). The injected current is mon itored via a current-to voltage converter 
to provide a measure of the total membrane current .  
[be experim ntal etup for TE 
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i s  depicted in Figure 3 .2  and 3 . 7 . t the 
beginning of the e periment , perfusi 11 contai ner and appl ication systems " ere 
fi l led \\ i tb the appropriate olution and al lo\ ed to run through the connected tubes. 
The experiments were perfon11ed u ing the TEVC techn ique. For each experiment, a 
ingle oocyte \Va placed in the rec rding chamber and cont inuously perfused with 
D96 solution at a rate of 3-5 ml/minute. The oocyte was impaled with two glass 
microelectrodes ( resistance ;:::; 1 -2 MQ) prepared using a vert ical m icroelectrode 
pul ler (heater and olenoid values were adjusted to a sett ing of 50 and 70, 
re pect ively;  David Kopf Instrument Tuj unga, CA, US ) and fi l led with 3 M KCl 
o lut ion.  Drugs were appl ied by a gra ity-based mult ichanne l  appl ication system via 
a micropipette posi tioned about 2-3 mm from the impaled oocyte. TEVC was 
achieved using a Genec lamp 500 ampl ifier (Axon Instruments, Molecular Devices, 
I nc . ,  unny ale, CA, SA),  connected to a PC computer loaded with 
electrophysiology software (Win  WCP, University of Strathc lyde, Glasgow, UK), 
for data acquisit ion. 
3.3.7 P a ra meters tested by eJect ro p hysiological reco rd i n gs 
3.3.7. 1 Concentrations response cu rve ( I Cso determ i n a ti o n )  
The oocytes were voltage-clamped at  a holding potential of -70 mV using a 
GeneClamp-500 ampl ifier (Axon I nstruments, Molecular Devices, I nc . ,  Sunnyvale 
CA, USA), and current response i nduced by appl ication of 1 00 IlM of acetylchol ine 
chloride (ACh) was recorded digita l ly on an I B M\PC. 
A typical experiment began with three to five control record ings of a7 nACh 
receptor ion currents induced by 1 00 IlM of ACh with five m inute i ntervals of 
6 1  
wa hing w i th 096 o lut ion.  The average of three to four stable read ings wa 
calculated a the contr I " al lle. Fol lowing the control recordings. the ooc)ie v as 
pcrfu cd for a total of 1 5  minutes \vith the selected concentration of tested 
compound . The average of t\\"o to three responses at the end of the 1 5  min drug 
appl ication were calculated to determine the effect of the compound . Subsequently, 
the appl icat ion of drug was topped and recovery recordings were taken for the 1 00 
�M Ch again with 5 mi nutes intervals  ofND96 perfusion. 
The percent inh ibit ion was calculated by d ivid ing the average of currents 
induced in pre ence of the selected concentrat ion of the tested compound by the 
m erage control \ al ues obtained before drug appl icat ion.  These values were 
normal ized and d i  p layed as percent of changes in  current size (compared to 
controls) .  Monoterpenes such as carveol and carvacrol were used at varying 
concentrations to construct dose-response curves. The concentrat ion of a compound 
which produced 50 % i nh ibi t ion of ACh-induced currents ( ICso) was determined by 
nonl i near cur\"e-fi tt ing and regression fi ts ( logist ic equat ion) using computer 
software (Origin. Orig inLab Corp . ,  orthampton, MA, U . S .A. ) .  D i fferent 
concentrat ions of compounds were plotted on the X-axis and % i nhibit ion of ion 
current of respective concentrations was plotted on the Y-axis .  Concentrations of 
drugs c lose to their I Cso values were employed for further studi es .  Also, 1 0 �M 
effect of monoterpenes such as L-carvone, eugenol,  van i l l i n  and (+)-pulegone was 
exami ned for comparison. Wi th the exception of van i l l in ,  a l l  compounds were water 
inso luble .  These compounds were first dissolved i n  1 00% dimethyl sulfoxide 
(DMSO) .  DMSO, at the final concentrat ion of 0.00 1 % (v/v) used in our studies, did 
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not induce a tati ti a l ly igni ficant effect on the maximal ampl i tudes of ACh­
induc d current . 
3.3.7.2 E xperiment on the com petit ive and  non-com peti tive nature of  
mono terpene i n h i b it ion 
Concentrat ion-re pon e cur e for ACh were determined by using increasing 
h con entrations tart ing from 3 flM to 3 mM. The effects of carveol on d ifferent 
concentrat ions of A h- induced current were determ ined in the absence and 
presence of this compound . During these e, periment , oocytes were voltage­
c lamped at a holding potential of -70 m V and tlu·ee gradual ly increasing 
oncentrat ion of ACh and maximal ACh (3 mM) \ ere used on a single oocyte. For 
an et of concentrations of ACh. experiment were repeated in  5 -6 different oocytes 
and percent i nh ibi t ion \Va calculated as described ear l ier. 
3.3.7.3 Exper iment on  the  voltage-dependency of d rug i n h ib i t ion 
Voltage-dependence of the compound's action was determi ned by holding the 
membrane potentia l  at d i fferent values for 30 s. At each point, membrane potential 
\Va returned to -70 m V, and subsequent readi ngs were taken every five minutes. 
During these experiments. ACh was used at a concentration of 1 00 flM .  Current­
voltage ( I -V )  relationships for ACh-induced currents were detelmined in the absence 
and presence of tested compound. 
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3.3.7 ..t E x periment  on  the  determ inat ion of a +2 contr ibu t ion to  ob en'ed d rug 
act ion 
In  thi ene 
aminophenox )ethane-
of e periment , 50 nL of B PTA ( l  ,2-bis( 0-
'-tetraacet ic ac id)  tock soluti n ( 1 00 mM)  was 
injected into ach oocyte ( ands, Costa & Patrick. 1 993) .  tock solution of BAPT 
\\ a' prepared in di  t i l led-\ ater and the pH was adjusted to 7.4 by C O H .  Fol lowing 
B PT - injections. oocyte were kept in D96 for 5 to 1 0  min,  and placed in  a 
096 olution conta in ing Ba2+ instead of Ca2+(prepared D96 sol ut ion contained 
1 . 8 m Ba h instead of 1 . 8 mM CaCh) .  I n  order to determine the contribution of 
intra e l lular Ca2+ levels, the effect of the tested compound on the ACh-induced 
currents in BAPTA injected oocytes were investigated in ei ther Ca2+ or Ba2+ 
conta ini ng D96 solutions, and the extent of drug  inhibi t ion vas compared. 
3.3.7.5. Experiments for determ i n ation of  the effect of  exposu re t i m e  on the  
compound 's  act ion 
In this set of experiments, the compound's perfusion t ime was changed 
start ing from zero exposure t ime (Ach is coappl ied with the tested compound 
without pnor i ncubation of that compound) to a maXlmum of 1 5  minutes of 
pre incubation with the compound.  Effect of i ncreasing exposure time was analyzed 
by comparing the change i n  percent inh ibit ion of the fi xed concentrat ion of the 
compound tested .  These experiments were repeated on 5-6 d ifferent oocytes. 
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3.3.8.  Data a n a ly j 
For the non l inear curve-fitting, the computer software Origin (Origin Lab 
orr·, rthampton, M , . . A . ) was u ed . erage alues \ ere calcu lated as the 
mean ± tandard error of the m an ( M) .  tat ist ical s ignificance was analyzed 
u ing tudent' t-test or OV as indicated. Concentrat ion-response curves were 
obtained b) fi tti ng the data to the logi t ic equat ion, 
y = Ema" / ( 1  +l· IECsor'} 
Wh re x [U1d ) are drug concentrat ion and response, respect i  ely, Emax is the 
l11<L'{imal  re ponse. ECso is the half-maximal concentrat ion, and on '  is the slope factor 
(apparent l -I i l l  coefficient) .  
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Chapter 4: Re u l ts 
4. 1 Funct ional  exprcs. ion of the h u m a n  a7-nACh receptor in  Xenopu oocyte 
ppl ication of 1 00 ll M of acety lchol ine (ACh) did not cause noticeable 
urrent in uninjected oocyte ( n= 1 1 ) or in oocytes injected with dist i l led water 
(n= ). When 00 tes i njected with cR A transcribed [rom cDN encoding the a7 
human nACh receptor were used, appl ication of 1 00 �lM ACh for 3 to 4 seconds 
call ed fa t inward Clm-ent that were rapidly desensit ized ( Figure 4 . 1 A, left panel ) .  
Co-appl ication of 30 nM a-bungaroto in ,  a potent nA hR antagonist obtained from 
nuke venom. \vith 1 00 llM ACh caused almost complete inh ibi t ion of ACh-induced 
current (n= 1 4) .  i ndicating that the re ponse was mediated by a-bungarotoxin­
ensi t ive neuronal a7 n ChRs (4 . 1 A, middle panel ) .  After a 30-40 minutes washing 
period, i ncomplete or no recovery of the neurotoxin effect was observed ( F igure 
4 . l A, right panel ) .  Data from these experiments is presented in  F igure 4 . 1 B . 
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Figu re 4 . 1 :  Functional expression of human a7 nACh receptors in Xenopus oocytes. 
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A. Records of currents induced by ACh ( 1 00 f1M) in control conditions ( left) during co-appl ication of 
30 nM a-bungarotoxin and ACh after 1 0  min pre incubation with 30 nM a-bungarotoxin (middle), 
and 1 5  m in fol lowing a-bungarotox in washout (right).  B. Bar presentation of the means of the 
maximal ampl i tudes of ACh-ind uced currents i n  d ist i l led water injected oocytes and human a7 nACh 
receptor cRNA i njected oocytes are shown on the left-side of the F igure 1 B. In oocytes injected with 
human a7 nACh receptor cRNA,  the mean maximal ampl itudes of ACh-induced currents in  the 
presence and absence of a-bungarotoxin (30 nM) were presented on the right-side of the F igure 1 8 . 
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-1.2 The effect of e lected monoterpenoid on the fu nct ion of  h u m a n  a7 nACh 
recep t o r  
I n i t ia l  c .  periment \\ er d ne  to creen the effects of various e l  cted 
monot rpen at 1 0 �l 1 concentration, on the function of a7 nACh receptors. 
Eugeno l .  d-carvone and van i l l i n  d id not ha e a ign i ficant effect on a7 nACh 
functi n. arvacro l ,  carveoL thymol and pu\egone caused variable i nh ib i tory effects 
of ACh ( I  00 �M)-evokcd CUlTents. arvacroL thymol and caIveol caused sign ificant 
effect' \\- h i le  pulegone caused weak inh i bi t ion (-20%) .  Carveol showed maximum 
i nhibi tion ( 5 7°,0) of 1 00 �M ACh-i nduced current through a7 nAChR-expressing 
OC) tes and therefore i t  was e lected for further in estigations. Summary of the 
effect f 1 - m inute bath appl ications of monoterpenes on the ACh-induced Ion 
currents are shovvn in  F igure -+ .2 .  
Traces of currents ho\ ing the inhib i tory effect of carveol are presented in  
F igure -+ . 3 .  I n  the e experiments, i n  the absence of  the tested mono terpene, maximal 
amp l itudes of currents e l ic i ted by the application of 1 00 �M ACh every 5 min 
remained unchanged i n  experiments last ing 50-60 m in  (control record i n  left panel of 
F igure 4 . 3  and open c i rc les i n  F igure 4 .4) .  However, bath appl ication of 1 0 �M 
carveol caused a gradual ly developing strong i nh ib i t ion of a7 nACh receptors 
(F igure 4 . 3 ,  middle pane l ) .  T ime-course of the effect of 1 0 � M  carveol appl ication 
for 1 5  min on the ampl itudes of ACh-induced currents i s  presented in  F igure 4 .4 .  
The inhibition by carveol was almost reversib le  within 1 0  to 1 5  min of washout 
period (F igure 4 . 3 ,  right panel ) .  I n  the presence of caveol ,  there was a stat ist ical ly 
s ignificant d ifference in  the amp l itudes ACh-induced currents ( n=7, ANOVA, P < 
0.05) .  
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I t  wa noteworthy that the inh ibitory effect of carveol \ as dependent on the 
appl ication or e, po ure period. depicted in F igure 4 .5 ,  wi thout prei ncubation. the 
coappl ication of carveol ( 1 0  J-lM) and Ch ( 1 00 J-lM ) caused mi nimal inhibit ion (0 
t ime point in the F igur 4 .5 ) .  However, incubation v i th carveol caused a s ign i ficant 
inhibit i  n v, hich reached a maximal Ie el with a half-ti me ( T I /2 ) of 3 .4 min ( n=4; 
F igure 4 . 5 ). the magnitude of carveo) effect \ as t ime-dependent. 1 0  to 1 5  min 
carveol appl icat ion was rout inely u ed in  the rest of the experiments to  ensure that 
equi l ibrium condit ion for the monoterpene act ion were achieved . 
Can'eo) ' inhibitory effect of a7 nAChRs was concentrat ion-dependent with 
IC50 of 8 .3± 0.9 J-lM ( Figure 4.6). Based on these findi ngs, 1 0  J-lM of carveol was 
employed rout inely in the rest of the experiments. 
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Fiu u re 4.2 :  Effects of selected monoterpenes on a7 nACh receptor-mediated ion currents. 
Bar-graph d isplaying the means of o 0 of effect of I OIl M of tested monoterpene on 1 00llM Ach 
el ic i ted a7 nACh currents. Data represents the mean ± S.E .M of ind icated n umber of oocytes. 
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Figu re 4.3: Current traces of carveol ' s  effect on a7 nAChR currents. 
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Records of currents activated by ACh ( 1 00 IlM )  in  control cond it ions ( left) during co-app l icat ion of 
1 0 ).lM carveol and ACh after 1 0  min pre-treatment with 1 0  �lM carveol (middle), and 1 5  m i n  
fol lowing carveol washout (right). 
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Figu re 4 ... : T ime-cour e of carveol inh ib it ion of a7 nACh receptor-mediated ion currents. 
Inhibi t ion of a7-nACh receptor is rever ible after wash out of carveol .  Data points represent the mean 
± S.E .M of 4 to 6 oocytes. 
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Fig u re "'.S: Time-dependence of carveol inh ibit ion o f a7 nACh receptor-mediated ion currents. 
I nhib it ion of a7 nACh receptor increases with the prolongat ion of carveol appl ication t ime.  The half 
m ax imal  inh ibit ion was reached within a hal f-t ime (1 1  2) of 3 .4 min. Data points represent the mean ± 
. E . M  of 6 oocytes. 
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Figu re 4.6: Concentration-dependent inhibitory effects of carveol on a7 nACh receptor CWTents. 
Can eol inh ibits the funct ion of a7 nACh receptor in a concentrat ion-dependent manner. Data points 
represent the mean ± S.  E . M  of 6 to 8 oocytes. The curve i s  the best fit of the data to the logistic 
equation described in  the methods. The l Cso is 8.3 ± 0.9 �M . 
.:t.3 The role of i n t racel lu lar  calc iu m  levels i n  ca rveol- i n h ib i t ion of 0.7 nACh 
receptor 
orne rnonoterpenoids were reported to alter i ntrace l lular Ca2+ homeostasis  in 
d ifferent cel l  types (Chang et aI, 20 1 1 ;  de Cerqueira et aI, 20 1 1 ) . In  the oocyte 
expression system, the i ncreased level of intracel lu lar Ca2+ can be detected by 
Ca2+ act ivated cr channel s  and concomitant al terations in the holding currents. I n  
control experiments, carveol a lone ( 1 0  11M for 1 5  m in )  did not alter the magnitude of 
hold ing current i n  oocytes voltage-clamped at -70 mY (n= 1 2 ), i nd icating that 
i ntracel l u lar Ca2+ levels  were not altered by carveol .  
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As previou I; mentioned, high Ca2+ permeabi l ity is an important 
phy iological characteri t ic  of u.7 nAChR (A lbuq uerque, 2009: Vernino el aI, 1 992). 
a2" -acti\' ated r channel have been hOVvn to be ex pre ed endogenously In  
Xenopu oocytes ( M i ledi ,  1 982) .  ctivat ion of a7 nAChR s  al lows influx of 
ufficient amount of Ca2+ to activate endogenou ly e. pressed Ca2+-dependent cr 
channel i n  Xenopus oocyte ( ands el aI, 1 993 ; Seguela el af, 1 993) .  Therefore, i t  
\,\ a nece sary to i nvestigate whether the effect of car eol  was mediated by its direct 
actions on a7-nAChR or by the subsequent act ivation of cr currents induced by 
Ca2 entry through nACh receptors. In this set of experiments, extracel l ular Ca2+ was 
replaced \\ith Ba2+ since Ba2+ can pass through a7-nAChRs but causes l i ttle, if any, 
activation of Ca2+-dependent cr channels  ( Bari sh, 1 983 ;  ands e f  aZ, 1 993) .  
In  the pre ence of Ba:!+, some activ i ty of Ca2+-dependent cr chan els  has 
been reported. The contribution of the remaining Ca2+-dependent cr channel act ivity 
has been shovvTI to be abol i shed b i njection of the Ca2+ chelator BAPT A ( Sands ef 
ai, 1 993) .  For tlns reason, we recorded ACh- induced currents in presence and 
absence of 1 o 11M carveol using BAPT A-injected oocytes bathed in a Bi+ containing 
sol ution. Carveol produced the same level of i nhib i t ion (54 ± 6 % i n  controls versus 
48 ± 7 % i n  BAPTA-injected oocytes n=5-8; ANOV A, P > 0.05)  of ACh-induced 
currents when BAPT A-injected oocytes were recorded in Ca2+ free, 2 mM Ba2+ 
containing solut ions (F igure 4 .7 ). 
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Figure 4.7:  Carveol inhibition of ACh-induced CU'Tents is independent o f Ca2+-acti ated c r  
channel . 0. 7  nACh expressing oocytes i nj ected with 5 0  n l  d ist i l l ed water and recorded i n  2 m M  
Ca�'" contain ing M B S  solution o r  inj ected with 50 11 1 of BA PTA ( 1 00 m M )  and recorded i n  2 mM 
Ba" contain ing M B  solut ion.  Data represent the means ± S .E .M of 1 0  experiments. There was no 
statist ica l l) sign i ficant d i fference in  the carveol ( 1 0 �M) inhibit ion i n  the presence or absence of 
B A PTA inject ion ( P>0.05, n=5 -8, ANOYA).  
-tA The voltage-dependence of  carveol act ion on the (17 nACh receptor 
Voltage-dependence of car eol - inh ibit ion was examined on a7 nACh 
receptors. Each tested membrane potential  was held for 30 s and then returned to -70 
mY. As shown in F igure 4 .8A,  the i nhibit ion of 1 00 11M ACh-induced currents by 
carveol ( 1 0  11M )  does not appear to be voltage-dependent. At a l l  tested membrane 
potentials from - 1 00 to -20 m V ,  the extent of carveol i nhibit ion were s imi lar. 
Evaluation of data from current-voltage relationship  d isplayed that there i s  no 
significant d ifference in  the extent of the inhibitory effect of carveol of a 7 nAChR 
currents at d i fferent holding potentials (F igure 4 .8B;  P>0.05 , n=6, ANOVA) .  
A 
B 
d 
0 . -..... . ...... 
..0 . -
...c 
d . -
� 
Voltage (rn V)  
- 1 20 - 1 00 - 8 0  -60 -40 -20 
1 00 
80  
60 
�t/I-t_,_! 40 
20 
o ������������ 
- 1 20  - 1 00 -80  -60 -40 
Voltage (n1 V) 
-20 
75 
-0 .2  
-0 .4  
-0 . 8 
- 1 . 0 
Figu re 4.8: Carveol inh ibit ion of ACh-i nduced currents is independent of membrane potential .  
A. Current-voltage relat ionsh i ps of ACh-activated currents i n  the absence and presence of carveol ( 1 0  J.1M) .  
ormal ized currents activated b y  1 00 J.1M A C h  before (Control, e )  and after LO  J.1M carveol treatment. B .  
Quantitat ive evaluat ion of t h e  effects of carveol is  presented a s  percent inh ib it ion a t  d ifferent voltages 
indicated in panel B. Data points represent the m ean ± S E M  of 7 to 8 experiments. 
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4.5 Stud ie on the com pet i t i  e or  non-com pet i t i  e na ture of  carveol '  i nh ib i tor"), 
effect of  0.7 n h receptor  
an eol ma) decrea e the binding of the agonist to  the receptor by act ing a 
ei ther a compet i t ive or non-competit i  e antagonist .  For this reason, the effect of 
carveol wa examined at di fferent concentrat ion of Ch.  Concentrat ion-response 
urves for h in the ab ence and pre ence of 1 0 �M carveol are presented in  
Figure 4 .9 .  Carveol caused a right-\ ard shi ft  of the concentration-response curve, 
without causing a decrea e on the the maximal ACh-induced current. In the absence 
and pre ence of can'eo l ,  the E 50 values were 94 ± 8 �M and 248 ± 1 4  �M (n=7), 
and sl pe value \ ere 1 .6 ± 0.2 and 1 . 7 ± 0.3 ( n=7),  respectively,  suggest ing that 
car\'eol i nhibi t  the Ch responses i n  a compet i t ive manner. 
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Figu re ...  9 :  Concentration-respon e curves for acety lchol ine-i nduced currents in the presence and 
absence of 1 0l-l M carveo ! .  
Ooc)te \."ere voltage-clamped a t  - 7 0  m Y  and currents were act i ated b y  applying acety lcholine ( 1 00 
�LM). Oocytes were exposed to 1 0  IJM carveol for 1 5  m in and ACh was reappl ied. Paired 
concentration-response curves \ ere constructed and responses normal ized to maximal  response under 
control conditions. EC50 and s lope alues were determ i ned by fitt ing the curves from 5 oocytes to the 
standard l ogistic equat ion as described in the methods sect ion. Data poi nts obtained before (Control) 
and after 1 5  min treatment with carveol ( l  0 �IM )  were ind icated by fi l led and open c irc les. Data points 
represent the normal i zed mean ± SEM of 6 to 8 experiment . 
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Chapter 5: Discu IO n  
] n  thi tud; , we provide electr ph siological evidence indicating that some 
monoterpenes inh ib i t  the function of human a7 n Ch receptor expressed in  Xenopll 
oocytcs. [her \\ ere signi ficant di fference in the effe t and the extent of activ i ty 
among the mon terp ne te ted in  thi study. At the same selected concentrat ion, 1 0  
p L van i l l i n howed \ ak acti vation « 1 0% of control readings), d-carvone almost 
had no e lTe t \\ h i l e  a l l  oth r monotepene demonstrated ariable extent of inh ibit ion. 
In the rder of potenc. of i nh ibitory effect of the ampl i tude ACh-induced currents, 
carveol \\ as mo t potent then thymol. car acroL pulegone and least is eugenol ( see 
F igure 4.2) . Further experiment focused on car eol,  being most potent among al l  
te ted monoterpenes. Our re ults demonstrated that pre incubation t ime was a 
ign ificant factor determin ing the extent of carveol i nh ibit ion. The t ime course 
required for carveol to show i ts effect on a7 nACh receptors was relatively slow ('r = 
3 .4 min ) .  This m ight indicate possible i nteraction of carveol with the l ipid 
membrane. As stated earl ier, monoterpenes are l i poph i l ic in nature and several in 
vitro studies on either art ific ial membrane systems, selected bacterial cel l s  or 
mammal ian cel l  l i nes demonstrated alteration of cel l membrane properties to 
variable  extents (Cristani et aI, 2007; de Carvalho & da Fonseca, 2007; Di Pasqua et 
aI, 2006: Reiner et aI, 20 1 3a; Reiner et aI, 2009) .  
Ion channel blockers can  ha e d ifferent mechan isms of actions. Depending 
on the type of ion channel and the blocker, the channel may be stab i l ized i n  the 
c losed state leading to decreased rate and/or duration of the opened state. Many 
blockers i nhibit  channel act iv i ty by physical ly  obstruct ing the channel pore near the 
select iv i ty fi l ter. Thi i s  knO\! n a pen-channel blockade ( l I i l le, 200 1 ) , 
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pen-channel blockade i "" idel accepted as a model to describe the block 
of l igand-gated ion channels ( I l i l le, 200 1 : Hi l le  & Dennis, 20 1 0) .  Howe er, this 
model cannot account for the re ul t  of the present tudy. F i rstl , for an open 
channel bl cker to act. the co-exi tenc of the agonist and blocker i requi red to 
al low the blocker to enter the channel pore as a result of agonist- induced 
COnf0n11ational change and channel open ing .  However, there was no i nh ibit ion of 
nA h receptor dur i ng coappl icaiton of ACh and carveol .  Increased preincubation 
period enhanced carveol- induced inhibit ion of  channel act iv i ty (F igure 4.4), 
i ndicating that carveol can interact \ i th the c losed state of the a7 nACh receptor. 
econdly,  i nh ibi t ion by car eol i not voltage sens i t i  e (F igure 4 .8 ) ,  suggest ing that 
the carveol-binding s i te is not influenced by the tran membrane electric field. 
In e lectrophysiological studies, the ECso alue of ACh, a natural l i gand 
(agonist )  for this receptor, i ncreased s ignificantly from 94 11M in controls to 248 11M 
in  the presence of  carveo l .  Efficacy of ACh remained unaltered i n  the presence of 
carveol . However, the potency was decreased significantly, i ndicat ing that carveol 
competes with the ACh binding s i te on the receptor. 
Earl ier studies i n  mammal ian ce l ls  showed that monoterpenes such as thymol 
( zentandrassy et af, 2004; Szentesi ef af 2004) and eugenol ( Lofrano-Alves et aI, 
2005) causes alteration of i ntracel l u lar Ca2+ hand l i ng and Ca2+ mediated signal 
transducti on pathways . As a7 nACh receptors are known to have h igh Ca2+ 
permeabi l ity, activation of those receptors i n  Xenopus oocytes can permi t  sufficient 
Ca2+ entry to possibly act ivate endogenous Ca2+ dependent c r  channels (Sands et aZ, 
1 993 ; Seguela et aZ, 1 993 ) .  Carveol was st i l l  able  to i nh ib i t  a7 nACh receptor-
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mediated ion current in oocyte injected vvith B PTA and superfused with Ba2+ 
contai ning o lut i  n .  ugge t ing that Ca2+ dep ndent c r  channels  were not invol d 
in carveol - induced inh ibi t ion of nicot inic re ponses ( Figure 4 .7 ) .  I n  addit ion, as the 
a2 act i \. ated r channels  are h ighl  sen i t ive to intracel lular levels of a2+ ( for a 
revlev" e Fraser & Djamgoz. 1 992; Machaca et aI, 2002 ; Weber, 1 999), the 
al terat ion in intracel l ular Ca2+ I vels would be r flected by changes in the hold ing 
current under voltage-clamp condi t ions. However, during our experiments, 
appl icat ion of carveo! ,  even at the h ighest concentrat ions ( 300 flM in n = 6), did not 
influ nce the basel ine r hold ing cur ents, suggest i ng that carveol did not affect 
intracel lu lar Ca2+ level . 
I t  appears therefore that the act ions of carveol reported i n  our study, are not 
mediated by changes in intrace l lular Ca2+ levels, and independent of the enterence of 
1+ extracel lu lar Ca- tIn-ough a7 nACh receptors. 
5. 1 M onoterpenes concentrations used in th is study 
Monoterpenes, in the concentration range used in the study have been shown 
to modu late the functions of several other receptors and ion channels .  For example, 
menthol causes concentrat ion-dependent i nh ibit ion of the a7 nACh receptors 
expressed i n  Xenopus oocytes with an ICso of 32 .6 flM (Ashoor et aI, 20 1 3a). An 
earl ier study showed that camphor i nh ibi ted nACh receptor function with an ICso of 
70 flM i n  bovine adrenal c1n-omaffin cel l s  (Park et aZ, 200 1 ) . Simi larly borneol a lso 
showed an inhib i tory effect on nACh receptors functions with a smal ler ICso of 56 
flM (Park et aZ, 2003) .  Also screening the effects of monoterpenes, thymol and 
carvacrol ,  on the functions of 5-HT type 3 receptors expressed in Xenopus oocytes, 
1 0  flM concentration, when coappl ied with smal l  concentration of 5 -HT ( EC2S) ,  
8 1  
cau ed igni ficant potentiat ion of the response ( Lan del l  el aI, 20 1 5 ). Moreover, 
pre\ IOU report sho\\ ed that coappl icat ion of 50 11M menthol with GABA caused 2 
fI ld potentiation of the re pon e to G B t\ receptors which are also expressed in  
Xenopus oocyte ( Hal l  ef  aI, 2004). Th mol showed s imi lar effects on  GABAA 
r ceptor concentration-dependently over the range 1 - 1 00 11M (Priest ley et aI, 2003) .  
The e resu lt ugge t that the concentrations of monoterpenes (Carveol ICso= 8 .3  
1 1  1 )  are in  n im i lar range to earl ier reports. 
5.2 Fu nct ional  im portance of monoterpenes act ions on h u m a n  (17 nACh 
receptor 
I t  ha been shown that a number of monoterpenes improve the cognitive 
perf0I111anCe i n  patients with cognit i  e d isorders such as Alzheimer disease (Dalai et 
al. 20 1 4 : Khan ef aI, 20 1 4 : Perry el ai, 2003 ; Perry et aI, 200 1 ;  V ideira et aI, 20 1 4) . 
Most of these studies demonstrated the value of tested monoterpenes in  Alzheimer 
d i sea e and improvement of cognit ive i mpairment through either ant ichol inestrase 
act iv i ty or i nhibi t ion of �-amyloid accumulat ion which is one of the key steps i n  the 
progression of the disease. Modulation of spec ific n icot in ic receptors i s  another 
possible mechanism that m ight be of value. S ince neuronal a4�2 and a7 nACh 
receptors have been strongly associated with cognit ive function ( Haydar & Dunlop, 
20 1 0: Levin, 2002: Okada et aZ, 20 1 3 ; Picciotto et ai, 2000) further i nvesti gations for 
the i nteraction of monoterpenes with these nACh receptor subtypes may be useful 
for drug development. I t  was evident from several ear l ier studies that agonistic 
effects on nicot in ic  receptors are associated with beneficial effects of various drugs. 
I nterest ingly, the monoterpenes tested in our study showed antagonistic  actions on 
a7 nACh receptors. 
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g ni t ic action of drug on nicotinic receptors can be mediated by 
act i \ ation of n h receptor or indirectl b increasing the release of 
neurotran mitt r ( for review, see Doro tkar & Boehm, 2008) .  Howe er, i t  has been 
hO\\ 11 in everal earl ier tudies that both nicot ine and n h receptor antagonists 
have almo t im i Jar ffe t ( nderson & Bnmze lL 20 1 2 ; Picciotto ef aI, 2008) .  For 
example. h igh doses of n ChR antagonists such as a-bungarotoxin, d-tubocurarine 
and mecam} lamine have been hown to cause excitatory responses (promoted 
populati 11 spikes) in rat CA 1 hippocanlpal s l ices that were s imi lar to those produced 
bJ nicot ine ( Ropert & Krnjevic, ] 982 ) .  Another stud u ing mouse hippocampal 
l ice demonstrated an increase in ampl i tude of population spikes caused by bath­
appl ication of nicotine and the antagonists such as d-tubocurarine and a­
bWlgarotox in  acted in a very s imi lar manner ( Freund et aI, 1 990). In another in vitro 
study, both nicotine and methy l lycaconi t ine (selective a7 nACh receptor antagonist) 
re\'er ed the musc imol  induced block of long-term potent iation (LTP) after their 
appl ication to CA l region of the h ippocampus ( F uj i i  et af, 2000a; Fuj i i  et aI, 2000b). 
Furthermore, appl icat ion of nicotine as wel l  as high concentration of the 
nicot in ic  antagonist mecanlylamine i ncreased serotonin release in rat dorsal 
h ippocampal s l ices despite smal ler concentration of the antagonist blocked nicotine­
induced effects when both were co-appl ied ( Kenny et af 2000; Mihai lescu et aI, 
1 998) .  Another study has shown that mecamylamine and the h igh-affinity 
antagonist ,  d ihydro-�-erythroid in, exerted effects s imi lar to nicotine on dopamine 
release under condi tions of phasic and tonic  act ivity ( Rice & Cragg, 2004). 
It was reported that mecamylamine, in low doses, promotes the perfomlance 
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in memo!) -related ta k to an extent comparable to nicotine. For in tanc , chronic 
admin istrat ion of 3 mg/kg do e of mecamylamine was found to reverse the nicotine­
induced improvement in  spatial \ orking memory in  the radial -ann-maze test ( Levin 
(!{ ai, 1 993 ) .  e\ erth less, when mecamylamine was gi en alone to tested rats, i t  
cau cd unexpected igni ficant improv ment in  rad ial -arm-maze working memory 
perfol1nance during the first week of infu ion (Levin et ai, 1 993) .  Using also radial­
Ul111 maze \\t ith repeated acquisit ion procedure low dose range of mecamylam ine 
showed signi ficant impro ement in  learning relative to sal i ne ( Levin & Caldwel l ,  
2006) .  I t  was al 0 hown that chronic admi ni strat ion of mecamylamine had complex 
effects u ing T-maze al ternat ion test. During the early phase of administrat ion, there 
was a paradoxical i mprovement in working memory performance, but during the 
latter period of admin istrat ion there was a deficit  ( Levin el 01, 1 997) .  Moran saw a 
s imi lar paradoxical improvement in  T -maze al ternation with mecamylamine when 
given as an acute inject ion of 1 0  mg/kg (Moran, 1 993) .  Corroborati ng evidence 
regarding the dose-spec i fic effects of mecamylami ne on memory was also gained 
using non-human primates as admini stration of mecamylamine caused i mproved 
perfonnance of delayed matching-to-sanlple accuracy in monkeys (Terry et of, 
1 999). S im i lar improvements i n  cognit ion were also evident fol lowing low doses of 
methyl l ycaconit ine, a selective a7 nAChR antagonist i n  a rodent model of attent ion 
( Hahn el 01 20 1 1 ) . In the absence of n icotine, low doses of methyl l ycaconit ine (0.4 
and 1 . 3 mglkg) improved response accuracy although concurrent admin istrat ion with 
nicoti ne caused reversal of n icotine-induced attention-enhancing effects. In the same 
study d ihydro-�-erythroid ine, a competitive antagonist at a4�2, a4�4, a3�2 and 
a2�2 nAChRs, a lmost showed almost no effect compared to contro l ,  indicat ing that 
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the a7 11 ChR ubrype may ha\ e a fundamental role in  cogn it ive function (Hahn ef 
01. 20 1 1 ) . The role of nA h receptor desen i t izat ion in  mediating the effects of 
nicotine and nic t in ic antagoni t has been re iewed recently (Buccafusco e/ ai, 2009· 
Picc iot t  ef aI, 2008). I t  ha been concluded that an overal l  decrea e in nicot in ic 
t imulation could be l i n ical l valuable for cogni t ive enhancement. I n  a recent study, 
group of researcher ( Dobry akova ef aI, 20 1 5 ) tudied the effects of d ifferent 
n icot in ic receptor antagonists on passi e avoidance learning in rodents and 
demon trated that mecamylamine, when given after a t rain ing phase, had posi tive 
effects on memory consol idat ion.  In a pi lot study ( Potter et aI, 2009) where human 
partic ipants i .e .  fi fteen non-smoking young adu l ts d iagnosed with attention deficit 
hyperact iv i ty d i  ord r (ADHD),  received, in  a double-bl i nd fashion, an acute, s ingle 
dose of mecamylamine ( 0 .2 .  0.5 or 1 mg) oral ly  and placebo. Mecamylamine 
sho·wed beneficial  effects on recognit ion memory with the 0 .5  mg dose. S imi lar 
fi nd ing on recogni tion memory was demonstrated when acute nicot ine dose was 
given for young adolescents with ADHD ( Potter & Newhouse, 2004; Potter & 
ewhouse, 2008 ). 
The s imi larit ies in effects of nicotine and nAChR antagonists were also seen 
at cel l ular Ie el and on receptor regulation. Continuous treatment with 
mecamylam i ne in vivo or in vitro experiments was reported to cause brain region 
spec ific and/or subtype-specific  upregulation of nACh receptors in  a way s imi lar to 
the effect of n icot i ne ( Abdul l a  et aI, 1 996; Col l ins et aI, 1 994; Pauly et aI, 1 996' 
Peng et aI, 1 994) .  Some studies have demonstrated modulation of downstream 
signal i ng events as a resu l t  of nACh receptor antagonism. In vitro exposure of PC 1 2  
cel l s  to nicot ine (0 .0 1 - 1 0  I-lM)  for 24 hours produced an i ncrease i n  the level of 
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xpr\,; ion of trop my in receptor kina e A (TrkA) receptors. high affin i ty nerve 
gro\\1h factor recept r .  that was reversed upon concurrent exposure to 
mecamylaminc (5 �l I )  (Jonnala ef ai, 2002 ). Interestingly, expo ure to low 
concentration of mecamylamine 1 0- 1 00 nM) in the ab ence of nicotine also induced 
a igni ficant increa e in expres ion of TekA receptors with reference to contro l .  
Con istent with the in vitro findings, in vi1'o administration of mecamylamine (24 
mg/kg/day) cau ed a moderate increase (20%) in expression of TrkA receptors 
(Jonnala et ai, 2002). This uggests a po ible neuroprotect ive effect of nACh 
receptor antagoni t that is impoltant for delaying or preventing neural degeneration 
a ociated with cognit ive deficits. Col lectively, these effects may contribute to the 
procogni t ive effects of n Ch receptor antagonism. 
A described earl ier, a7 nACh receptors are characterized by fast 
desensit ization, and this  makes it d i fficult  to d iscriminate whether the effects of a7 
nACh receptor agonists are due to d i rect activat ion or subsequent activat ion-induced 
receptor desensit ization ( Banerjee et aI, 2005) .  Binding of agonists stabi l izes the 
de ensit ized state of the receptor. This state d isp lay h igh affini ty for ACh and other 
l igands binding, nevertheless, receptor becomes unresponsive to subsequent 
st imulus .  As a resul t ,  chronic exposure to n icotine was demonstrated in animal 
studies and in smoking hwnan subjects to induce strong compensatory receptor 
upregulation ( Benwel l  el aI, 1 988 ;  Parker el aI, 20 1 4; Perry et ai, 1 999). In th is 
context, i t  has been suggested that many of the n icot in ic effects can be explained as a 
resul t  of receptor desensi t izati on rather than activation (P icciotto et ai, 2008) .  I t  i s  
sti l l  unclear whether agonists of nACh receptors are tru l y  functioning i n  vivo as 
antagonists due to desensit ization process. 
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Chapter 6: Coo clu 1 0 0  
Monoterpene di  p lay variable biological act ivi t ie l i ke anaJge i c ,  ant i ­
in flammatory and anticancer effect . Th is  is ,  to  our knowledge, the first study 
report ing effects of everal monoterpenes on the function of the human a7-
nA h receptor, a l igand-gated ion channel .  The results obtained in th i s  study 
ugge ( an i nh ibitor effect of monoterpenes on the function of a7 nACh 
receptors. It appears that the extent of inhibi tory act ion varies signi ficantly 
among the d ifferent monoterpene . 
6. 1 Lim itat ion a n d  fu tu re d i rections 
I n  our study, \ e d id not exami ne monoterpenes effects on mammal ian 
cel l  l ines and nati e neurons. I t  i s  possible that post-translat ional modi fication 
and interacting proteins in Xenopus oocytes are d ifferent from mammal ian cel ls .  
In future studi es, we intend to study the effect of monoterpenes on the other 
nicotinic ACh receptor subtypes to determi ne the spec ific ity of monoterpenes 
act ion on these receptors. We are also interested in conduct ing experiments to 
further study the structure activ i ty relat ionship  of these phytochemicals on 
nicotinic receptors expressed in mammal ian cel l l i nes. 
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